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Hematopoiesisare a prototype for development from adult pluripotent stem cells. While T-cell
speciﬁcation is driven by Notch signaling, T-lineage commitment is only ﬁnalized after prolonged Notch
activation. However, no T-lineage speciﬁc regulatory factor has been reported that mediates commitment.
We used a gene-discovery approach to identify additional candidate T-lineage transcription factors and
characterized expression of N100 regulatory genes in early T-cell precursors using realtime RT-PCR. These
regulatory genes were also monitored in multilineage precursors as they entered T-cell or non-T-cell
pathways in vitro; in non-T cells ex vivo; and in later T-cell developmental stages after lineage commitment.
At least three major expression patterns were observed. Transcription factors in the largest group are
expressed at relatively stable levels throughout T-lineage speciﬁcation as a legacy from prethymic precursors,
with some continuing while others are downregulated after commitment. Another group is highly expressed
in the earliest stages only, and is downregulated before or during commitment. Genes in a third group
undergo upregulation at one of three distinct transitions, suggesting a positive regulatory cascade. However,
the transcription factors induced during commitment are not T-lineage speciﬁc. Different members of the
same transcription factor family can follow opposite trajectories during speciﬁcation and commitment, while
factors co-expressed early can be expressed in divergent patterns in later T-cell development. Some factors
reveal new regulatory distinctions between αβ and γδ T-lineage differentiation. These results show that T-
cell identity has an essentially complex regulatory basis and provide a detailed framework for regulatory
network modeling of T-cell speciﬁcation.
© 2008 Elsevier Inc. All rights reserved.Introduction
T-cell development is an exceptionally favorable system in which
to examine the mechanism of differentiation from stem cells in
general. It offers the most completely identiﬁed sequence of
developmental intermediates known for any post-embryonic stem-
cell derivatives. Cells with T-cell precursor activity become physically
segregated from other blood-cell precursors by migrating to the
thymus at a very early stage of their development (Shortman andWu,
1996; Ceredig and Rolink, 2002; Petrie and Zuniga-Pﬂucker, 2007;
Rothenberg et al., 2008). This allows these intermediates to be puriﬁed
for analysis with minimal interference from irrelevant cell popula-erg).
hysics, Los Alamos National
Science Center, University of
l rights reserved.tions. Also, because individual T-cell precursors can be isolated
relatively easily, it has been possible to deﬁne the series of distinct
steps at which particular developmental alternatives are lost during
the stages leading up to lineage commitment (Rothenberg, 2007). T-
lineage speciﬁcation is both triggered and sustained by Notch
signaling. Yet the way lineage-speciﬁc gene expression actually starts
and how T-lineage identity is cemented at commitment are both
questions still to be resolved.
T lymphocyte development from hematopoietic stem cells is not
driven by a single “master gene”, but rather depends upon a large
number of distinct regulatory factors, as shown by genetic evidence in
targeted mutant mice (Anderson, 2006; Rothenberg and Taghon,
2005). Notch pathway signaling, triggered by ligands in the thymic
microenvironment, is a central element, needed both to begin T-cell
speciﬁcation and to complete lineage commitment. However, to
promote T-lineage development this signal must act on cells that also
have an appropriate constellation of intrinsic regulatory activities.
Among the transcription factors already known to have critical roles
are GATA-3, Myb, Runx1+CBFβ, Ikaros, TCF-1 activated by Wnt, RBP-J
445E.-S. David-Fung et al. / Developmental Biology 325 (2009) 444–467activated by Notch, basic helix–loop–helix “E proteins”, Gﬁ1, and in an
early hit-and-run role, hematopoietic transcription factor PU.1. Most
of these regulatory inputs are needed to allow recognizable T-lineage
precursors to emerge in the thymus from the earliest stages, long
before the cells express T-cell receptors for antigen and undergo
selection events that depend on those receptors. Most of the same
factors are then used repeatedly over many cell cycles for days or
weeks to deﬁne T-cell subtypes (Rothenberg et al., 2008; Ho and Pai,
2007; Tanigaki and Honjo, 2007; Anderson, 2006; Rothenberg and
Taghon, 2005; Staal et al., 2001).
Although identities of these factors are clear, the transcriptional
mechanisms that result in T-cell speciﬁcation have remained more
obscure than those involved in speciﬁcation of many other hemato-
poietic cell types, especially as contrasted with another lymphoid cell
type, namely B lymphocytes (Rothenberg, 2007; Rothenberg and
Taghon, 2005). B cell identity is now known to be created through the
action of a cascade of transcription factors in which key roles are
played by EBF and Pax5, two dedicated factors that are B-lineage
speciﬁc in expression as well as function within the hematopoietic
system (Cobaleda et al., 2007; Singh et al., 2007; Nutt and Kee, 2007;
Hagman and Lukin, 2006). Because of their speciﬁc expression
patterns, mutations in these factors also yield selective defects in B-
cell development that can be staged and characterized in molecular
terms. These factors also act effectively as positive B-lineage regulators
in both gain of function and loss of function experiments. The result
has been a deﬁnitive elucidation of the B-lineage speciﬁcation process
(Cobaleda et al., 2007; Singh et al., 2007; Nutt and Kee, 2007; Hagman
and Lukin, 2006). There are indeed twowell-studied factors that are T-
lineage speciﬁc in expression, namely GATA-3 and TCF-1 (product of
the Tcf7 gene), and it has been known for years that these are both
required speciﬁcally for T-cell development (Verbeek et al., 1995; Ting
et al., 1996; Hattori et al., 1996). However, in marked contrast to the B-
cell factors, these do not appear to upregulate T-lineage target genes
speciﬁcally and do not enhance T-cell development in gain of function
experiments (Taghon et al., 2007; Kirstetter et al., 2006; Scheller et al.,
2006; Baba et al., 2005; Staal et al., 2004; Anderson et al., 2002a). One
possible interpretation of existing data is that T-lineage choice is
fundamentally different from B lineage choice; but another possibility
has been that the EBF and Pax5 equivalents for T cells simply have yet
to be recognized. Therefore, a crucial question is whether other
transcription factors may exist in early T-lineage cells that could play
more cell-type speciﬁc roles.
This study and its predecessors (Tydell et al., 2007; Anderson et al.,
1999) were undertaken to identify any “missing” regulators of T-cell
development that may be T-cell lineage speciﬁc, to track the major
changes in transcription factors generally as cells progress toward T-
lineage commitment, and to clarify how their roles and expression are
coordinated with the observed landmarks in T-cell development
(Rothenberg et al., 2008). In this study, we have relied on cDNA
macroarray screening for gene discovery and on sensitive, quantitative
realtime RT-PCR (qPCR) measurements to identify a large group of
regulatory gene candidates and track the way that they and their
family members are expressed in early T-lineage precursors. The
results show that the T-cell speciﬁcation process entails discontinuous
upregulation of one group of transcription factor genes, surprisingly
stable expression of a larger group of stem cell-inherited factors until
after commitment, and downregulation of another substantial group
of previously expressed transcription factor genes. However, few
regulatory genes overall have highly speciﬁc T-cell expression, and
while T-lineage commitment also causes upregulation of certain
transcription factor genes, most of these are not T-lineage speciﬁc.
These results add substantial detail to the transcription factor
dynamics that underlie T-cell speciﬁcation and strengthen the
probability that there is a fundamental divergence between the
overall regulatory strategies involved in T-cell and B-cell lineage
choice.Materials and methods
Animals
Cells were obtained from C57BL/6 mice and from mice of TCRβ−/−
and Rag2−/− genotypes on a C57BL/6 background, all maintained in our
breeding colony at the California Institute of Technology (Caltech).
“Adult” samples were from 4–6 week old mice for thymocyte isolation
and from 8–12 week old mice for bone marrow isolation. Fetal liver
was obtained from timed pregnancies of C57BL/6 or (C57BL/6×DBA/2)
F1 mice at E14.5 (day of plug=E0.5). Animals were kept in
microisolator cages in an AAALAC-accredited facility with the
immune-deﬁcient mutants maintained with sterilized cages, water,
food, and bedding. Euthanasia and animal care followed NIH guide-
lines, under protocols approved by the Institute Animal Care and Use
Committee.
Gene discovery by macroarray screening
NewcDNAclones of interestwere isolated froma C.B17-Prkdcscid/scid
(SCID) mouse thymocyte cDNA library that was constructed and
arrayed onto four large nylon ﬁlters as previously described (Anderson
et al., 1999; Tydell et al., 2007). SCID thymocytes were used as starting
material because their mutant phenotype prevents T-cell develop-
ment from continuing through β-selection. Thus, N90% of these
populations naturally consist of T-cell precursors in the DN1–DN3
stages. To select for cDNAs that might encode gene regulatory factors,
four “macroarray” ﬁlters containing approx 73,000 clones were
screened as previously described (Tydell et al., 2007) with probes
designed to identify conserved domains associated with transcription
factors.
To make these initial probes, gene sequences of representatives
from various transcription factor families were aligned using
ClustalX, and primers were designed to their DNA binding domains
or protein interaction domains. Primers used are tabulated in Table
1. The putative functional domain coding regions were then
ampliﬁed from bulk SCID thymus cDNA and gel-puriﬁed. Domain-
speciﬁc DNA probes were generated by random priming in the
presence of α-32P dCTP, using the gel-puriﬁed PCR ampliﬁcation
products as templates. Probe was hybridized to the macro-array
ﬁlters overnight and washed with 3–4 low stringency washes to
enable fully and partially matched hybrids to be detected. Macro-
array ﬁlters were exposed to ﬁlm and clones identiﬁed by positively
hybridizing spot pairs that were picked from the archival library for
further analysis as previously described (Tydell et al., 2007). A total
of 1490 clones were selected into 96-well plates for sequencing and
re-arraying onto smaller nylon ﬁlters.
Sequencingwas performed by themodiﬁed Sanger's method at the
Institute for Systems Biology, Seattle, WA. The sequences were
identiﬁed by BLASTn, BLASTx (http://blast.ncbi.nlm.nih.gov/Blast.
cgi), and BLAT alignments against the GenBank “nr” databases and
the mouse genome (up to builds 35 and 36; http://genome.ucsc.edu).
New sequences that appeared to encode transcription factors or
potential transcription-modifying factors, as well as sequences that
deﬁned new splice isoforms of known transcription factor genes, were
submitted to Genbank as Expressed Sequence Tags (accession
numbers listed in Table 2).
Primary T-lineage cell samples
Cell populations of interest were collected by ﬂuorescence-
activated cell sorting (FACS), and cells were processed in Qiazol
(Qiagen, USA) for RNA. RNA was puriﬁed using Qiagen RNAeasy kits
(Qiagen), and treated with RNase-free DNaseI (Ambion) to remove
genomic DNA contamination before conversion into ﬁrst strand cDNA
using Superscript Reverse Transcriptase (Invitrogen).
Table 1
Conserved domain primers for macroarray screen
A. AT-Hook
AT-Hook.For 5′-ctccgaaagagcccagtgaa-3′
AT-Hook.Rev 5′-ggtttcctccctggagctgt-3′
B. ARID
ARID.For 5′-ggacctttgaggagcagttcaa-3′
ARID.Rev 5′-ctcataggggtaaagatacttcat-3′
C. bHLH
MyoD.For 5′-ccaccaacgctgatcgccgcaa-3′
MyoD.Rev 5′-cgcagcagagcctgcagacctt-3′
D. Bromodomain
Bromo.For 5′-catcattaaacaccccatggacctcagta-3′
Bromo.Rev 5′-gctcacctggcatcttggcaaatctcat-3′
E. Chromodomain
Chromo.Chd1-For 5′-caaccatttatgctgtcgaa-3′
Chromo.Chd1-Rev 5′-ctgctgcttcagggtctctt-3′
Chromo.Cbx/Mpc2-For 5′-cttcgcggtggagagcat-3′
Chromo.Cbx/Mpc2-Rev 5′-cctttccctgttctggaa-3′
F. Cut-Homoeodomain
Cux.For 5′-gtcaaggaggtgctcaccgacaa-3′
Cux.Rev 5′-cagccacagctgcatacgcacaa-3′
G. Ezrin–Radixin–Moesin (Protein interaction)
ERM.For 5′-gacctgaagaccacatacgatgaa-3′
ERM.Rev 5′-ctgcagggtctgcctggccagtt-3′
H. Forkhead box
Fox.For 5′-tcacctatgccacccttat-3′
Fox.Rev 5′ctcctcttcttgcgaaactca-3′
I. GCM box
GCM.For 5′-gcgcaacaccaacaaccacaa-3′
GCM.Rev 5′-cttctgccttctgtctctgactt-3′
J. HLH
Myf5.For 5′-caggctggccactgcctcat-3′
Myf5.Rev 5′-gttggtggtggtgcacctctt-3′
K. HMG box
SOX.For 5′-gcaagccccatgctaagct-3′
SOX.Rev 5′-ggtgattggcatggcggct-3
L. Homoeodomain
HOXB4.For 5′-cggagctcggccaagtctatga-3′
HOXB4.Rev 5′-ccggttatggaacgagatcttga-3′
M. Leucine zipper
TSC.For 5′-gtgggaccgagccgctgcagat-3′
TSC.Rev 5′-gtcttcagcagattgttctcct-3′
N. LIM domain
Lim-1.For 5′-cggagattaccagagtgagta-3′
Lim-1.Rev 5′-gcaagctgggctcaggacta-3′
4.5Lim.For 5′-gtcaggaatgccacaagcccat-3′
4.5Lim.Rev 5′-gcacaggatattcttgtccca-3′
O. NFAT
NFAT.p-For 5′-ctcctctgccagcttcatt-3′
NFAT.p-Rev 5′-ggcagaggagcaaccaaa-3′
NFAT.x.For 5′-cctttgagtgcccaagtatccaa-3′
NFAT.x.Rev 5′-gagatgctgctggcaggacta-3′
P. PAS
AHR.PAS-A.For 5′-caggcgctgaatggctttgt-3′
AHR.PAS-A.Rev 5′-cttctgtatggatgagctcat-3′
AHR.PAS-B.For 5′-cgaaccaaaaacttcatcttca-3′
AHR.PAS-B.Rev 5′-gtctgcagcatggatgaact-3′
PER.PAS-A.For 5′-ggaacccggataccttcgctgt-3′
PER.PAS-A.Rev 5′-acgtcatgaggagccaggagct-3′
PER.PAS-B.For 5′-gatccctcctgagaagaggat-3′
PER.PAS-B.Rev 5′-cagatcctgaggtaggtaa-3′
Q. PDZ
PDZ.For 5′-cctctgacaatctctagtctgaa-3′
PDZ.Rev 5′-ctttgtagagtcatattcaa-3′
PDZk1.For 5′-gcagaggcagctggcttgaa-3′
PDZk1.Rev 5′-ccagcaccaacagagtagt-3′
LAP.For 5′-gttgcgtttgctcagacgaga-3′
LAP.Rev 5′-caagcttgatgcaccgcgacgct-3′
WEGbox.For 5′acagataatgggggttgggct-3′
WEG/PHD.Rev 5′-gtattgaacattgtctgcgccatt-3′
R. PHD
PHD.For 5′-gtgcttgcatgacatgtaataaa-3′
WEG/PHD.Rev 5′-gtattgaacattgtctgcgccatt-3′
ZIP/PHDf.For 5′-cagcagcattgaacagaagga-3′
ZIP/PHDf.Rev 5′-ggtagtcccctttcatgttat-3′
S. REL
NFkB.For 5′-gctattcggtgagtaaagaa-3′
NFkB.Rev 5′-gtttttgtagccctattttcat-3′
T. RNA binding domains
hnRNP.A2/B1-For 5′-ggctgcaaggcctcattccatt-3′
hnRNP.A2/B1-Rev 5′-gcctatcggtaattatttcaatagt-3′
hnRNP.U-For 5′-caggggcgaggcagggccaa-3′
hnRNP.U-Rev 5′-gacacaccgtaggaagctctt-3′
hnRNP.x-For 5′-ggagagtggtgcacgtatcaa-3′
hnRNP.x-Rev 5′-gcaaccaccttttccaataaga-3′
Rbm.For 5′-gaaccagaggtgcttcaagaa-3′
Rbm.Rev 5′-cccttggtaatggatactcat-3′
U. STAT
STAT.For 5′-gaccctgtccctccctgtggt-3′
STAT.Rev 5′-cccatgatagccccatcattcca-3′
V. T-box
T-box.For 5′-gagatgatcatcactaagcaa-3′
T-box.Rev 5′-ggcagcctctggctctccat-3′
W. Zinc ﬁngers
Btb/Poz
BTB/POZ.For 5′-catttgctgcagtgcctgaacgagca-3′
BTB/POZ.Rev 5′-catctggagatagttggcagctgcaa-3′
ROG.For 5′-ggcaggagcaactaggatgat-3′
ROG.Rev 5′-ggtcagtgggatcctctgat-3′
C2H2
Multizf.For 5′-gcctcacagatcaccgaga-3′
Multizf.Rev 5′-ggaagaggcttaaattgtt-3′
Fog
FOG.For 5′-gccccaggatgaagagaaa-3′
FOG.Rev 5′-gcagtctttgcaggggaa-3′
Gli
GLI.spfc-For 5′-gagacaaactgccactgggat-3′
GLI.spfc-Rev 5′-gctcacagatgtaaggcttct-3′
Groucho
Grg.For 5′-gaaatgcacaaacagactgaaat-3′
Grg.Rev 5′-ggtgcttcttgtcatcttttatt-3′
Ring Finger
Ring/B-box.For 5′-gatcgaggatcttctgta-3′
Ring/B-box.Rev 5′-ggcctcatgattgctgta-3′
ZIC
ZICspfc.GLI-For 5′-ctgttccgcaaccgtggctt-3′
ZICspfc.GLI-Rev 5′-gggcagcatagtgctcggat-3′
Table 1 (continued)
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depletion with magnetic beads and multiparameter ﬂuorescence-
activated cell sorting (FACS) were used as previously described
(Taghon et al., 2006; Yui and Rothenberg, 2004; Anderson et al.,
1999). DN subsets were sorted from wild type C57BL/6 mouse thymi
that were ﬁrst depleted for CD3, CD8,TCRβ, TCRγδ, NK1.1, Gr-1, F4/80,
B220, and Ter119. For “Series A”, cells were sorted into DN1 (or ETP,
early T-cell precursor) (CD117+ CD44+ CD25−), DN2 (CD117+ CD44+
CD25+), DN3 (CD117−CD44−CD25+), andDN4 (CD117−CD44− CD25−).
For “Series B”, cells were sorted into DN1, DN2, DN3a, and DN3b
subsets using CD27 to split the DN3 subsets as described previously
(Taghon et al., 2006), and isolating DN4 cells as CD44− CD25− CD24+.
To examine DN subsets from Rag2−/− mutant thymus, ﬁrst 10% of
dissociated thymocytes were reserved to sort for DN2=Thy1.2+ CD44+
CD25+ and DN3=Thy1.2+ CD44− CD25+ stages. The remaining 90%
cells were depleted of CD24, Gr-1, F4/80, and Ter119 and then sorted to
separate Sca-1+Thy1- (precursor-enriched) and “pre-NK”=Sca1− Thy1±
subsets (David-Fung et al., 2006). These “pre-NK” cells are strongly
enriched for expression of NK cell genes such as perforin and Id2
(Wang et al., 2006; David-Fung et al., 2006; Wang et al., 1998).
To analyze the development of fetal hematopoietic precursors
developing in OP9-control or OP9-DL1 culture, Lin− c-Kit+ CD27+
multilineage precursors (Lin=Ter-119, CD19, F4/80, Gr-1) were
isolated by FACS and cultures were established exactly as described
previously (Taghon et al., 2005). In these experiments, OP9-control
cultures generated B cells predominantly while OP9-DL1 cultures
generated T cells. Samples were generated from two independent
large-scale time course experiments, one of which was a 10-day time-
course also used for previous analyses (Taghon et al., 2005; Tydell et
Table 2
EST sequences from SCID thymocyte library
Gene Alternative
name
EST ID# GenBank
accession #
Date
submitted
ARHGEF2 39175456 EB739685 5/10/2006
39175457 EB739686
ARID1A 39175458 EB739687 5/10/2006
39175459 EB739688
BAHD1 39175460 EB739689 5/10/2006
39175461 EB739690
BRD3 38305921 EB359574 4/6/2006
38305922 EB359575
38305923 EB359576
BTF3 39175462 EB739691 5/10/2006
39175463 EB739692
CBX4 39175464 EB739693 5/10/2006
CEBPd 39175465 EB739694 5/10/2006
39175466 EB739695
CENTb1 39175467 EB739696 5/10/2006
CIZ Zfp384 39175468 EB739697 5/10/2006
39175469 EB739698
39175470 EB739699
39175471 EB739700
39175472 EB739701
39175473 EB739702
CRABP1 39781094 EC277794 6/8/2006
39781095 EC277795
CSF2Ra 39781134 EC277834 6/8/2006
39781096 EC277796
CTBP2 39781097 EC277797 6/8/2006
39781098 EC277798
CUTL1 39781099 EC277799 6/8/2006
39781100 EC277800
DAPLE CCdc88c 39781101 EC277801 6/8/2006
39781102 EC277802
39781103 EC277803
39781104 EC277804
DBP 39781105 EC277805 6/8/2006
39781106 EC277806
DIMP Dmtf1 39781107 EC277807 6/8/2006
39781108 EC277808
DSC43 39781109 EC277809 6/8/2006
39781110 EC277810
39781111 EC277811
39781112 EC277812
39781113 EC277813
39781114 EC277814
39781115 EC277815
39781116 EC277816
39781117 EC277817
ELK3 39781118 EC277818 6/8/2006
39781119 EC277819
39781120 EC277820
39781121 EC277821
39781122 EC277822
ELK4 39781123 EC277823 6/8/2006
39781124 EC277824
39781125 EC277825
ESR1 39781126 EC277826 6/8/2006
39781127 EC277827
39781128 EC277828
39781129 EC277829
39781130 EC277830
39781131 EC277831
39781132 EC277832
39781133 EC277833
FLI1 39877808 EC365110 6/13/2006
39877809 EC365111
39877810 EC365112
39877811 EC365113
39877812 EC365114
GATA3 39877813 EC365115 6/13/2006
39877814 EC365116
GIMAP6 39877815 EC365117 6/13/2006
GNAI2 39877816 EC365118 6/13/2006
39877817 EC365119
GSE1 39877818 EC365120 6/13/2006
39877819 EC365121
(continued on next page)
Table 2 (continued)
Gene Alternative
name
EST ID# GenBank
accession #
Date
submitted
HKR2 Zscan22 39877820 EC365122 6/13/2006
HKR3 39877821 EC365123 6/13/2006
HMGA1 38305924 EB359577 4/6/2006
38305925 EB359578
38305926 EB359579
38305927 EB359580
38305928 EB359581
38305929 EB359582
38305930 EB359583
38305931 EB359584
38305932 EB359585
38305933 EB359586
IARS2 39877822 EC365124 6/13/2006
IKAROS 39877823 EC365125 6/13/2006
39877824 EC365126
39877825 EC365127
39877826 EC365128
39877827 EC365129
39877828 EC365130
39877829 EC365131
39877830 EC365132
JMJD3 39877864 EC365166 6/13/2006
39877831 EC365133
39877832 EC365134
39877833 EC365135
KLF2 39877834 EC365136 6/13/2006
39877835 EC365137
39877836 EC365138
39877837 EC365139
39877838 EC365140
39877839 EC365141
39877840 EC365142
39877841 EC365143
39877842 EC365144
39877843 EC365145
KLF13 39877844 EC365146 6/13/2006
39877845 EC365147
39877846 EC365148
39877847 EC365149
39877848 EC365150
39877849 EC365151
39877850 EC365152
39877851 EC365153
39877852 EC365154
39877853 EC365155
KLF15 39877854 EC365156 6/13/2006
39877855 EC365157
39877856 EC365158
39877857 EC365159
39877858 EC365160
39877859 EC365161
39877860 EC365162
39877861 EC365163
39877862 EC365164
39877863 EC365155
MTA2 40881949 EE265166 8/3/2006
MTA3 40881950 EE265167 8/3/2006
40881951 EE265168
NCOR2 40881952 EE265169 8/3/2006
PAX1 40881953 EE265170 8/3/2006
40881954 EE265171
PCBP2 40881955 EE265172 8/3/2006
40881956 EE265173
PER1 40881976 EE265193 8/3/2006
40881957 EE265174
POU2F1 40881958 EE265175 8/3/2006
40881959 EE265176
40881960 EE265177
40881961 EE265178
POU6F1 40881962 EE265179 8/3/2006
40881963 EE265180
40881964 EE265181
PPARd 40881965 EE265182 8/3/2006
40881966 EE265183
PPRC1 40881967 EE265184 8/3/2006
(continued on next page)
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Table 2 (continued)
Gene Alternative
name
EST ID# GenBank
accession #
Date
submitted
PURB 40881968 EE265185 8/3/2006
RARa 40881969 EE265186 8/3/2006
40881970 EE265187
40881971 EE265188
RBAK 40881972 EE265189 8/3/2006
40881973 EE265190
40881974 EE265191
40881975 EE265192
SBF1 41528217 EE663535 8/24/2006
SFPI1 41528238 EE663556 8/24/2006
41528249 EE663567
SOX4 41528260 EE663578 8/24/2006
41528271 EE663589
41528176 EE663494
41528187 EE663505
41528189 EE663507
41528190 EE663508
41528191 EE663509
41528192 EE663510
SPI-B 41528193 EE663511 8/24/2006
SUPT5h 41528194 EE663512 8/24/2006
41528195 EE663513
TBX21 41528196 EE663514 8/24/2006
41528197 EE663515
41528198 EE663516
TCF3 E2A 41528199 EE663517 8/24/2006
41528200 EE663518
41528201 EE663519
41528202 EE663520
41528203 EE663521
41528204 EE663522
TCF7 38305934 EB359587 4/6/2006
38305935 EB359588
38305936 EB359589
38305937 EB359590
38305938 EB359591
38305939 EB359592
38305940 EB359593
38305941 EB359594
38305942 EB359595
38305943 EB359596
TCF12 HEB 41528205 EE663523 8/24/2006
41528206 EE663524
41528207 EE663525
41528208 EE663526
41528209 EE663527
THRAP3 41528210 EE663528 8/24/2006
41528211 EE663529
TLE3 41528212 EE663530 8/24/2006
41528213 EE663531
41528214 EE663532
TMSB4X 41528215 EE663533 8/24/2006
41528216 EE663534
TRIM24 41528218 EE663536 8/24/2006
TRIM25 EFP 41528219 EE663537 8/24/2006
41528220 EE663538
TRIM28 41528221 EE663539 8/24/2006
TSC22d1 41528222 EE663540 8/24/2006
41528223 EE663541
41528224 EE663542
YY1 38305944 EB359597 4/6/2006
38305945 EB359598
38305946 EB359599
ZBTB20 39175474 EB739703 5/10/2006
39175475 EB739704
ZBTB7a 41528225 EE663543 8/25/2006
41528226 EE663544
41528227 EE663545
41528228 EE663546
41528229 EE663547
41528230 EE663548
41528231 EE663549
41528232 EE663550
41528233 EE663551
41528234 EE663552
41528235 EE663553
Table 2 (continued)
Gene Alternative
name
EST ID# GenBank
accession #
Date
submitted
ZC3H5 41528236 EE663554 8/25/2006
41528237 EE663555
ZFP3 41528239 EE663557 8/25/2006
41528240 EE663558
ZFP28 41528241 EE663559 8/25/2006
ZFP32 ZFP637 41528242 EE663560 8/25/2006
41528243 EE663561
ZFP36 l2 41528244 EE663562 8/25/2006
41528245 EE663563
41528246 EE663564
41528247 EE663565
41528248 EE663566
ZFP41 41528250 EE663568 8/25/2006
41528251 EE663569
ZFP90 41528252 EE663570 8/25/2006
41528253 EE663571
ZFP95 Zkscan5 41528254 EE663572 8/25/2006
41528255 EE663573
ZFP110 41528256 EE663574 8/25/2006
41528257 EE663575
ZFP238 41528258 EE663576 8/25/2006
41528259 EE663577
ZFP286 41528261 EE663579 8/25/2006
41528262 EE663580
ZFP287 41528263 EE663581 8/25/2006
41528264 EE663582
ZFP316 41528265 EE663583 8/25/2006
41528266 EE663584
ZFP358 41528267 EE663585 8/25/2006
41528268 EE663586
ZFP422 41528269 EE663587 8/25/2006
41528270 EE663588
ZFP598 41528272 EE663590 8/25/2006
41528273 EE663591
ZFP672 41528274 EE663592 8/25/2006
41528275 EE663593
ZFP691 41528276 EE663594 8/25/2006
41528277 EE663595
ZFPN1A4 Eos, Ikzf4 41528278 EE663596 8/25/2006
41528279 EE663597
41528280 EE663598
41528281 EE663599
ZIP67 41528177 EE663495 8/25/2006
41528178 EE663496
41528179 EE663497
41528180 EE663498
41528181 EE663499
41528182 EE663500
41528183 EE663501
ZIPRO 41528184 EE663502 8/25/2006
41528185 EE663503
ZKSCAN1 41528186 EE663504 8/25/2006
41528188 EE663505
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phenotypes were re-sorted after the ﬁrst two days, returned to OP9
coculture, and harvested after just 4 days overall. Some samples from
these time-courses were also sorted again at day 4 to re-isolate cells
retaining the Lin− c-Kit+ CD27+ precursor phenotype and to separate
these from CD27− Mac-1+/Gr-1+ cells that had also been generated in
the cultures.
To assess gene expression in later T-cell development, thymic cells
from wild type C57BL/6 mice were sorted by FACS directly to isolate
double positive (DP) and single positive CD4+ cells, while another
aliquot of the thymocytes was ﬁrst depleted of CD4, B220 and NK1.1
expressing cells and then sorted to isolate double negative (DN) and
single positive CD8+ cells. The markers used were: DN=CD24+ CD4−
CD8−, DP=CD4+ CD8+, CD4 SP4=CD4+ CD8−, CD8 SP=TCRβ + CD24−
CD4− CD8+. TCRγδ cells were obtained from TCRβ−/− thymocyte
populations that were depleted for CD4 and CD8 prior to sorting for
expression of CD3ɛ and TCRγδ. To assess non-T lineage expression in
Table 3
Primer sequences used for Quantitative PCR
Newa primers Gene tested Alternative name Primer sequences (Forward; Reverse) Comments
Titration qualityb
+ 4632433K11Rik AK014606 5′-ACAAGACTGACAGAGAAGACTTACAGAAA-3′
5′-GGGCTAAAAGGACTTGGGAGTT-3′
Actb β-actin 5′-ACACCCGCCACCAGTTC-3′
5′-TACAGCCCGGGGAGCAT-3′
Aff3 LAF4 5′-TGACACCTCCCACCATGGA-3′ ⁎(−)
5′-TTTCCTCCGTAACGCATTCC-3′
+ ARID1a Smarcf1 5′-ACGTGGGCGTTAGACACCAT-3′ ⁎(−)
5′-AATATTCCACAAGGAGCTCTAGCAA-3′
+ Atxn2l 5′-CTCTCCCTGACCCCTACAGA-3′
5′-CAGGGACTTTCCCAGCTAT-3′
+ B2m β2-microglobulin 5′-TCACTGACCGGCTTGTATGCT-3′ Used in preliminary analysis only
5′-TGAGGCGGGTGGAACTGT-3′
+ Bahd1 mKIAA0945 5′-TCCCGCTTGGAGGGATTC-3′
5′-AGTCCCCTGCTCCATATTGCT-3′
Bcl11a CTIP1 5′-GTCTGCACACGGAGCTCTAA-3′ Tydell et al. 2007
5′-CACTGGTGAATGGCTGTTTG-3′
Bcl11b CTIP2 5′-GGGCGATGCCAGAATAGAT-3′ Primers from Tydell et al. 2007
5′-GGTAGCCTCCACATGGTCAG-3′
+ Bcl6 5′-GTGGAGATGAAGCCTGTAGCA-3′ ⁎⁎(−); Not expressed in thymocytes
5′-CACTTGAATCGTGCAGTGGTA-3′
+ Brd3 5′-AAATGCAGGTTCCCAACAAGTG-3′ ⁎(−)
5′-CGGCAATGACGGGTGTCT-3′
+ Brd4 5′-CCCTGAAGCCATCTACACTACGA-3′
5′-ACCAGCAATCACGTCAACTTT-3′
+ Cbx4 5′-AGCTGATGGGATATCGCAAGAG-3′
5′-GTCTTGAAGCCCAGTCAGAACAT-3′
+ Ccdc88c Daple 5′-CCTGGGTGAAAACTTTTGGA-3′
5′-CTGGGGTCTATTTGCAGCAT-3′
Cd3e 5′-CGTCCGCCATCTTGGTAGAG-3′
5′-ATTCAATGTTCTCGGCATCGT-3′
Cd3g 5′-TGGAGAAGCAAAGAGACTGACA-3′
5′-GCCATCCACTTGTACCAAATTC-3′
Cebpa C/EBPα 5′-CGGTCATTGTCACTGGTCAACT-3′ ⁎(++) Only one intron
5′-GGACAAGAACAGCAACGAGTACC-3′
Cebpb C/EBPβ 5′-GTTTCGGGACTTGATGCAATC-3′
5′-CGCAGGAACATCTTTAAGGTGAT-3′
Cebpd C/EBPΔ 5′-TCCACGACTCCTGCCATGTA-3′
5′-TGAAGAGGTCGGCGAAGAGTT-3′
Cebpg C/EBPγ 5′-GCGCAGGTACATGTGAAGATT-3′
5′-CTGCGACAGCTTGCTCATT-3′
+ Cep170 KAB1 5′-GCCGAGCATCCTGATCACTT-3′ First thought to interact with KRAB domains
5′-AGAGAACTGAAAGACTGATGACAATAGC-3′
+ Csf2ra1 GM-CSFRα 5′-CACCGCGTCCTGTAACTCTT-3′ Data not shown; exp. declines DN1–4
5′-GCGCTCTGCCACTGGACCTCAAACT-3′
+ Ctbp1 5′-TGAGTCAGAGCCCTTCAGCTTT-3′ ⁎(−)
5′-CAATGGACGCCTGCTCACT-3′
+ Cutl1 5′-CCATGGAAACTGTCTCTGTCTTCA- ⁎(+)
5′-TGTCAGACTAGCTGGGTTGTTTG-3′
+ Dmtf1 Dimp 5′-ACACGGACGGGAATCTCATTC-3′ ⁎(+)
5′-AATGCTTTGATCATCCTCAGAGG-3′
Dtx1 Deltex1 5′-GAGGATGTGGTTCGGAGGTA-3′ ⁎(−)
5′-CCCTCATAGCCAGATGCTGT-3′
Elf4 MEF (myeloid Ets) 5′-CAGGCTCACCAAAACTGTGA-3′
5′-TTGGTCAGCACCGTAGTCAG-3′
+ Elk3 ERP 5′-CTGAGCAGAGCGCTGAGATAC-3 ⁎⁎(+)
5′-TTCAGGATATCCGGGAAAGAG-3′
+ Elk4 5′-GCTTTTCCAGTTTCCCTCTGT-3′
5′-TCTGCAGGTCTGGAGAAAATG-3′
+ Erg 5′-GCCTCCCAATATGACCACAA-3′
5′-TATTCTTTCACCGCCCACTC-3′
+ ESR1 Estrogen receptor 1 5′-GCTCCTGGACAGGAATCAAG-3′
5′-CTTCTCCCTGCAGGTTCATC-3′
Ets1 5′-AAAAGTGGATCTCGAGCTTTTCC-3′
5′-CTTTCAAGGCTTGGGACATCA-3′
Ets2 5′-GCAAGGCAAACCAGTTATTCCT-3′
5′-ACTTGTCAGAGAGTAGCTCCAGAAGAA-3′
+ Etv6 TEL 5′-TCCTGCTGCTGACCAAAGAG-3′
5′-CTGGCTTGGTGTGGATAGAG-3′
+ Fli-1 5′-ACAGACCAGTCCTCACGACTGA-3′
5′-CTTTTGTTGAGGCCAGAGTTCAT-3′
+ FoxJ3 5′-TGATCCCGGAAAGGGTTCTT-3′ ⁎(−)
5′-AGGCCCGTTCTACGGATCTT-3′
+ Foxp1 5′-CTGGAAAACAGCCGAAAGAG-3′
5′-GGTTGGAGGGGAAGGGCAGG-3′
(continued on next page)
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Table 3 (continued)
Newa primers Gene tested Alternative name Primer sequences (Forward; Reverse) Comments
Titration qualityb
+ Foxp4 5′-CCCACAACCCTACCTTCTTCATC-3′ ⁎(−)
5′-GGGACCGGAGAACTAATTTTCA-3′
Fus 5′-CAGCAACGAGCTGGAGACTG-3′
5′-TCTGGCTTAGGTGCCTTACACTG-3′
+ Gabpa 5′-TGCACTGGAAGGCTACAGAAAA-3′ ⁎(−)
5′-TTACCCAAACCACCCAATGC-3′
Gapdh 5′-ACTCCACTCACGGCAAATTCA-3′
5′-GCCTCACCCCATTTGATGTT-3′
Gata2 5′-ACCACAAGATGAATGGACAGAA-3′ ⁎(−)
5′-GTCGTCTGACAATTTGCACAAC-3′
Gata3 5′-GAGGTGGTGTCTGCATTCCAA-3′ Called “Gata3-endog” in Taghon et al. 2007
5′-TTTCACAGCACTAGAGACCCTGTTA-3′
Gata3 (alternate) 5′-CCTGCGGACTCTACCATAAAA-3′ In coding region; Taghon et al. 2007
5′-GTGGTGGTGGTCTGACAGTTC-3′
Gﬁ1 5′-AGCGTCGGAGAAGTCACTGT-3′
5′-CAGGTCAGACCCAGCAAGAC-3′
Gﬁ1b 5′-CCTTTGCCTGTGATGTCTGT-3′
5′-ATGAACGCTTGAAGGCTTTG-3′
+ Gse1 5′-GGGATTGAGGCAATCTTTGA-3′
5′-GGCTGAGGCTGTAGTTCTGC-3′
HEBAlt 5′-GTGCTTATCCTGTCCCTGGAATG-3′
5′-TGGCTTGGGAGATGGGTAAC-3′
Hes1 5′-TACCCCAGCCAGTGTCAACA-3′
5′-TTCTTGCCCTTCGCCTCTT-3′
Hes1 (alternate) 5′-CCAAGCTAGAGAAGGCAGACA-3′ Alternate primers, Yui and E.V.R. 2004; data not
shown but similar5′-CGGTATTTCCCCAACACG-3′
+ Hmga1 HMG-I(Y) 5′-AAAGTATCACCGGGTGGGTTTC-3′
5′-CATTAAAGTGGGTGGAGCCAAC-3′
+ Hprt 5′-GAGCTACTGTAATGATCAGTCA-3′
5′-ACCAGCAAGCTTGCAACCTT-3′
Id1 5′-GGCGAGATCAGTGCCTTG-3′ ⁎⁎(+)
5′-AAGGGCTGGAGTCCATCTG-3′
Id2 5′-GTCCTTGCAGGCATCTGAAT-3′ ⁎(+) Possible detection of genomic DNA?
5′-CTCCTGGTGAAATGGCTGAT-3′
Id3 5′-AGAGGAGCTTTTGCCACTGA-3′ ⁎⁎(−)
5′-TGGAGAGAGGGTCCCAGAGT-3′
Ikzf1 Ikaros 5′-TCCCAAGTTTCAGGAAAGGA-3′
5′-TCTGCTGTGCTCCAGAGGTA-3′
Ikzf2 Helios 5′-CACCTCAGGACCCATTCTGT-3′
5′-TGACAGCGTTCCTTGTGTTC-3′
Ikzf3 Aiolos 5′-CCGAGATGGGAAGTGAGAGA-3′ ⁎(−)
5′-CGCTTCTCACCGATGAATTT-3′
+ Ikzf4 Eos; Zfpn1a4 5′-CCCAAACAGCCAACACTCTT-3′
5′-TTATCCAGGAGCCGTTCATC-3′
Il2rb IL-2/15Rβ 5′-ACGTCCATGCCAAGTCGAA-3′
5′-GGAACGACCCGAGGATCAG-3′
IL2-UP Il2 ﬂanking seq. 5′-ACCTTGGGAGCTGAAATCCT-3′
5′-TTTTGAGGGATCGCTAATGG-3′ Detects genomic DNA; Adachi and E.V.R. 2005
Il7ra IL-7Rα 5′-AGTCCGATCCATTCCCCATAA-3′ ⁎(−)
5′-ATTCTTGGGTTCTGGAGTTTCG-3′
+ Jmjd3 5′-CCCTACCCCCAGCATCTATT-3′
5′-GCCTAAGTTGAGCCGAAGTG-3′
+ Klf13 5′-CGGGCTGCGAGAAAGTTTAC-3′
5′-GAGCGTGCGAACTTCTTGTT-3′
+ Klf15 5′-TTTTCCCGCTCAGATGAGTT-3′ ⁎(+) No expression in thymocytes
5′-GCGATGCACTTTGATGTGTT-3′
+ Klf2 5′-ATGCACCTGAGCCTGCTAGT-3′ ⁎(+) crosses tiny intron
5′-ATAGCACTGCCCTCTCCCTCT-3′
Lat 5′-CTGTTGTCTCCTCTGCTCCTGT-3′
5′-CTCACTCTCAGGAACATTCACG-3′
Lck 5′-CTAGTCCGGCTTTATGCAGTG-3′
5′-CCGAGGGAGTCTTGAGAAAAT-3′
Lef1 5′-ACCTACAGCGACGAGCACTT-3′
5′-GGGTAGAAGGTGGGGATTTC-3′
+ Lima1 Eplin a: 5′-AGGAGAGCTGCGTGGAGTGT -3′ ⁎⁎(−)
5′-GCAGTAGGAGCATCGGAAACAG-3′
+ b: 5′-AGGAGAGCTGCGTGGAGTGT-3′ ⁎(−)
5′-TGCAGTAGGAGCATCGGAAAC-3′
Mit 5′-CCCCAAGTCAAATGATCCAG-3′ Taghon et al. 2007
5′-CCTTAGCTCGTTGCTGTTCC-3′
+ Mlf2 5′-ACCAGGAGACGTCGGAGATG-3′
5′-GCCCTATCCCGAATGTGATG-3′
MLL1 ALL-1 5′-TGCCCATAGCCCATCATCA-3′
5′-TCTGTGAATGAGGCCGATCTG-3′
MLL2 5′-CCCGGTCCCGAATCAAAC-3′
5′-GAAGAGAACCACGGTATTTTGCAT-3′
450 E.-S. David-Fung et al. / Developmental Biology 325 (2009) 444–467
Table 3 (continued)
Newa primers Gene tested Alternative name Primer sequences (Forward; Reverse) Comments
Titration qualityb
+ Mta2 Mta1l1 5′-CTGAAGACCCCTACCCAACTTG-3′
5′-CCCGGTTAGCACTGGTTGTATAG-3′
+ Mta3 5′-CGTGCCGTGGGAACATTT-3′ ⁎(+)
5′-GTGTGTCCATGGCATGAAACA-3′
Myb c-Myb 5′-GAGCAGAAGAAGTTTCCCGATTT-3′
5′-AGCGGGAATCGGATGAATCT-3′
Mybl2 B-myb 5′-AAGGAGGTGCTCCGTTCTGA-3′
5′-CCAGAGACTTGCGGACCTTCT-3′
+ Myst3 MOZ 5′-CCAGTGCTGAAGGGAAAGAG-3′ ⁎(+)
5′-ACAGATGGGGATTGGTTCAG-3′
+ Nasp 5′-TGTAGCCGAACTGGCACTGA-3′
5′-TTCTACTGGCAATCATGGATACTGA-3′
+ Ncor1 5′-AATCTCATCCCCTATTAAACCAAACC-3′
5′-GTATATTACATGGAGTGCAAGAAACCA-3′
+ Ncor2 5′-CGCACACCGGATCCTAGAAG-3′
5′-TCCGCTTAAAGTACAAGATCAGCTT-3′
Nfe2 5′-TATGCAGCTTTTGGCAGAGA-3′
5′-GAGGGGCAGTGAAGACTGAA-3′
+ Pax1 5′-GGCAATGACCTTCAAACACC-3′ No expression in thymocytes
5′-CTGTGAGAGGACAGCCCCTA-3′
Pax5 5′-ACAGGACATGGAGGAGTGAATCA- 3′ Anderson et al. 2004; no expression in T
5′-CCTTGATGGGCAAGTTCCACTA-3′
+ Per1 Period 5′-CCGAATACACACTTCGAAACCA-3′
5′-CGAAACACATCCCGTTTGC-3′
+ Pou2f1 Oct1 5′-AACCACCAACCTGCAACCA-3′ ⁎⁎(−)
5′-TGCTGAGGTAGTTGCGTTAAAAGAT-3′
+ Pou5f1 Oct4 5′-GGAAAGGTGTTCAGCCAGAC-3′ No expression in thymocytes
5′-CTCATTGTTGTCGGCTTCCT-3′
Pou6f1 Brn-5 5′-CTGCAACTCCCATCCCAATC-3′ ⁎(−)
5′-CGCAAACTCCCGGATCTCTTCT-3′
Ptcra Pre-Tα, pTα 5′-CTGGCTCCACCCATCACACT-3′
5′-TGCCATTGCCAGCTGAGA-3′
+ Ptma Prothymosin α 5′-GGCGTGCCCCACCAT-3′
5′-CATTCTCTGCCTCCTCCACAAC-3′
+ Rara 5′-CTCCCAGGACCGCTTAACC-3′
5′-GGAGCTGCAAGTCCCAAGT-3′
+ Rbak 5′-TAAGTTGGAGCAGGGAGAAGAG-3′ Library-cloned new isoform
5′-CAATTCCTTCTCTGGGGTCATA-3′
+ 5′-TCGTCATGCTACACTGTGCACTAC-3′ Conventional isoform
5′-CCGGTGTGGACCCTTTGA-3′
+ Rnf149 5′-GGAATTGATGTCGATGCTGA-3′
5′-GCCATGGGTCAATGCATATT-3′
+ Rreb1 5′-TCACCACCAATGGGAACATG-3′ ⁎(−)
5′-AACCGCCTGCGCTTCAG-3′
Runx1 5′-CTCGGCAGAACTGAGAAATG-3′
5′-GGTGATGGTCAGAGTGA-3′
+ Runx2 5′-GCCTCCGCTGTTATGAAAAA-3′ ⁎(+)
5′-TGGGGAGGATTTGTGAAGAC-3′
Runx3 5′-GGTTCAACGACCTTCGATTC-3′
5′-GGTCCATCCACAGTGACCTT-3′
+ Saps1 mKIAA1115 5′-TTCATTGGCTCAACGAAGAGA-3′ ⁎(+)
5′-GGCTTAGGCGGATGATGTCA-3′
Satb1 5′-CCACAAACACGGAGGTCTCT-3′
5′-GCAATCCCTGAGTTCGGTTA-3′
+ Sbf1 5′-AGGAGCTGCTGGATGTGATT-3′ ⁎(+)
5′-CCATGCTCAGAACATTGTGG-3′
Sfpi1 PU.1 5′-CCCGGATGTGCTTCCCTTAT-3′
5′-TCCAAGCCATCAGCTTCTCC-3′
Sox4 5′-TCAAGGACAGCGACAAGATTC-3′
5′-GCCGGTACTTGTAGTCAGGGTA-3′
SpiB-1 SpiB, ex3–4 5′-CTGCAAGCCCTTCAGTTACC-3′ See Dionne et al. (2005); David-Fung et al. (2006)
5′-AAAGGCAGCAGTAGCAGGAT-3′
SpiB-2 SpiB, ex1–2 5′-CTTGCTCTGGAGGCTGCAC-3′ ⁎(−); used in Yui and Rothenberg (2004)
5′-CCCCCATCTGAATCTGGGTA-3′
+ Stat5b 5′-GCTGTATCCGGCACATTCTGT-3′ ⁎⁎(+) Serious titration anomaly
5′-GTTTGGTTGATCTGAAGGTGCTT-3′
Tal1 SCL 5′-CTCACTAGGCAGTGGGTTCTTT-3′ ⁎(−)
5′-GGACCATCAGAAATCTCCATCT-3′
+ Tbx21 T-bet 5′-AGGTGTCTGGGAAGCTGAGA-3′ ⁎⁎(+)
5′-ATTCGCCGTCCTTGCTTAGT-3′
Tcf12 HEB (canonical) 5′-GAGAAGAAGACCGCTCCATGAT-3′
5′-TGGCTTGGGAGATGGGTAAC-3′
Tcf7 TCF-1 5′-CAAGGCAGAGAAGGAGGCTAAG-3′ Intra-exon: detects N-term half of the HMG domain:
“Tcf7.8”5′-GGCAGCGCTCTCCTTGAG-3′
(continued on next page)
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Table 3 (continued)
Newa primers Gene tested Alternative name Primer sequences (Forward; Reverse) Comments
Titration qualityb
Tcf7 (alt primers) TCF-1 5′-TGCTGTCTATATCCGCAGGAAG-3′ ⁎(+) Crosses from exon III to IV: “Tcf7.3”;
Taghon et al. (2005)5′-CGATCTCTCTGGATTTTATTCTCT-3
Tcfe2a E2A, Tcf3 5′-CAGATGGTGGCCTGGATACT-3′
5′-CATCCCTGCTGTAGCTGTCA-3′
+ Tfdp1 5′-GATAGGTGAATGGATCAGAGGTTAAGA-3′ ⁎⁎(−)
5′-CCTTGGAACTGGAGTCACAGACTT-3′
+ Thrap3 5′-GTTGTGCCGTTGCGAGAT-3′ ⁎⁎(+) Serious titration anomaly
5′-CTTGGGCGTGTACTTTGGAT-3′
+ Tle3 5′-TTGCGAAGAGACTGAACACAAT-3′
5′-GCGTTCAACTCCGTCATGGT-3′
Tox 5′-CCATGGACCTGCCAGAGATC-3′
5′-TTCTGCGTTCCCAATCTCTTG-3′
+ Trim25 Efp 5′-CGGAAAATTCGACACCATCT-3′
5′-CCTTGCAATTTTGCAGCTTT-3′
Trim44 5′-TCTGTGTCCTGTGTCCAGTCATT-3′
5′-CAGTCCACCGGAATCTTTGC-3′
+ Tsc22d1 5′-AAACGCTTCCGTGAGACTTG-3′ ⁎(+)
5′-TCACCGCATACATCAAATGG-3′
+ Unk 5′-GTTGGGGCAGAGTACCTGAA-3′
5′-ACGTCCTGTTTGGGTTGAAG-3′
+ Yy1 5′-GCCAGAATGAAGCCAAGAAA-3′
5′-GGTGTGCAGATGCTTTCTCA-3′
+ Zbtb20 5′-CAGCCAAACAGAACTACGTCAA-3′ ⁎⁎(−)
5′-TGCTACACTGGTACGCTCTCA-3′
+ Zbtb48 5′-TGTCCCACATGTCACAAAAAGTT-3′ ⁎⁎(+)
5′-TCTCCTTGCGGAAGTAACACTTC-3′
+ Zbtb7a LRF, Pokemon 5′-CCCTACGAGTGTAACATCTGTAAAGTTC-3′ ⁎(+) More sensitive due to shorter amplicon than for
primers in Maeda et al. (2007)5′-GTGGTTCTTCAGGTCGTAGTTGTG-3′
+ Zfp1 mKr1 5′-TGGAAGTGTGGAAGGCTGATG-3′ ⁎(−)
5′-TTTCTTCAGTTGGTGGTTGGTTC-3′
Zfp109 5′-GCTGCTCAGAGGAAGCTGTA-3′
5′-CCCCAGTGAAAGGCATCTTA-3′
+ Zfp110 5′-ATGATGGAGAACTACAGCAACATGA-3′ ⁎(−)
5′-TGCATTGGCCAGCAGTCTT-3′
+ Zfp238 5′-CGTCCTGTGATGAGAGTGATGT-3′ ⁎(+)
5′-TGGCTCATACTGTACCCTGTTG-3′
+ Zfp28 mKr5 5′-TGTACTCAACATCGGAGACTTCACA-3′
5′-CTCCGTGACATCTACGATGACAG-3′
+ Zfp287 5′-CCCAAGAAGACTGGGAACTG-3′
5′-ACCATCCACGGCTCTTCTAA-3′
+ Zfp316 5′-CCCGGGTATCTCCCACTACT-3′
5′-TACACGGCCACATCTTCAAA-3′
+ Zfp358 5′-CATCGGGTCCTGTTCCAG-3′ ⁎(+)
5′-GGTCTCCATAAAGGGGCCTAA-3′
+ Zfp382 KS1 5′-AAACCTGATATGATCCGCAAGT-3′
5′-TCACCAAAACTTCCTCCTCTTC-3′
+ Zfp384 CIZ 5′-GATTCCGCATGGTGAAGAGT-3′
5′-GTTACCGCTACCTGCTTCCA-3′
+ Zfp407 5′-TTCAGGGAGTCCTGCAGTTT-3′
5′-TGATGAACTGGGAGCCTTCT-3′
+ Zfp422 5′-CGAAGGGAATTCCGAGTTG-3′ ⁎(+)
5′-AAATACCCCCTTTGGGCTTT-3′
+ Zfp426 5′-AAGCCAGACCTGAAATAAACCAGT-3′ ⁎⁎(−); Known mRNA
5′-AGAGGCAATCTCCATTCCTCTTAA-3′
+ 5′-TCCTAGTCTGACCCCCTGGTT-3′ ⁎(−); Novel mRNA
5′-GCTTAGAGTCACATAGGTCCTCTTCA-3′
+ Zfp598 5′-CAGGTGGTCTTTGGGAAGAA-3
5′-TGCAAACACCTTTCCATCTG-3′
+ Zfp748 2610014M12Rik 5′-ACACCCGCCACCAGTTC-3′
5′-TACAGCCCGGGGAGCAT-3′
+ Zfp771 DSC43 5′-GGGCAGCGAGGGGCACTT-3′
5′-CACTTGGGACTGGCACCTGAATTGTTCC-3′
Zfpm1 FOG-1 5′-GCCTCACTGAGGGCCTATCC-3′
5′-TCCTTAGCCAGCAGCTCTCATC-3′
+ Zkscan1 5′-CAGGGCTCTGAGAACAGGAATGG-3′
5′-CTGTTCCCGTTTCTCTCCAA-3′
+ Zkscan5 Zfp95 5′-CGTGGCTGTGATAGAGAGTATCCA-3′ ⁎⁎(−)
5′-GTGGCTCCGGGTGGTACC-3′
+ Zkscan21 Zipro 5′-CCGTCACTCTCCTGGAAGAC-3′
5′-GCCGTTCCTGAAGTTGACAT-3′
+ Zscan22 5′-CCGTTCTGGTGGAGGATATG-3′
5′-GGTGGCTCCAATTCATCTGT-3′
a For original references to primer pairs that are not marked by “+”, see Anderson et al. (2002a,b, 2004); Hernández-Hoyos et al. (2003); Yui and Rothenberg (2004); Dionne et al.,
2005; Taghon et al. (2005, 2006, 2007); Franco et al. (2006); David-Fung et al. (2006); and Tydell et al. (2007).
b Notations about titration curves: all slopes fall within the range of −3.0 to −3.7 ΔCT per tenfold dilution except as indicated: ⁎(−) slopes −2.6 to −2.99; ⁎(+) slopes −3.71 to −4.1;
⁎⁎(−) slopes shallower than −2.6; ⁎⁎(+) slopes steeper than 4.1.
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mutant bone marrow as described previously (Tydell et al., 2007).
Quantitative real-time reverse transcriptase-dependent PCR
Quantitative reverse transcriptase-dependent PCR (qPCR) was
performed to measure gene expression in different samples of cDNA
from the cells described above. Primers were designed to genes of
interest using the PrimerExpress™1.5 (ABI) or Primer3 (http://fokker.
wi.mit.edu/primer3/input.htm) programs. They were designed as far
as possible to span introns of N200 bp length, to avoid ampliﬁcation of
genomic DNA. Intron–exon information was veriﬁed from Ensembl
(http://www.ensembl.org) and UCSC mouse genome assemblies.
Primers utilized are shown in Table 3. Many primer sets used in this
study have also been reported previously (Anderson et al., 2002a,
Anderson et al., 2002b, 2004; Hernández-Hoyos et al., 2003; Yun and
Bevan, 2003; Yui and Rothenberg, 2004; Dionne et al., 2005; Taghon et
al., 2005, 2006, 2007; David-Fung et al., 2006; Franco et al., 2006;
Tydell et al., 2007). Standard curves were run for new primers to select
sets with dilution curves giving close to the theoretical value of ΔCT
3.3 per tenfold dilution. Note the anomalous titration behavior of two
primer sets, Stat5b and Thrap3 (Table 3), which should be treatedwith
caution, but the great majority showed ampliﬁcation consistent with
1.8–2.0 fold ampliﬁcation per cycle. Samples were run in triplicate on
an ABI Prism 7700 or 7900HT realtime PCR machine, and thresholds
were set uniformly across all genes analyzed with a particular
reference standard to calculate ΔCT=CT(gene)−CT(standard). Levels
of expressionwere converted to units of β-actin or GAPDH expression
using the formula: expression=(1.9)−ΔCt.
Each gene was interrogated in at least two independently sorted
sets of samples (two sets=1 “Series”) for veriﬁcation of gene
expression patterns, and key genes were analyzed in four or more
independently sorted sets of samples. Sorted cell cDNA inputs were
routinely normalized by expression of GAPDH and β-actin; in early
analyses, expression of Hprt was also assessed (not shown). To test for
genomic DNA contamination in cDNA samples, primers IL2-UP, from
the upstream non-transcribed region ﬂanking the mouse IL2 gene
were used (Adachi and Rothenberg, 2005). In general, patterns of
expression deﬁned by changes in level N3 fold were highly
reproducible among independent experiments [also see (David-Fung
et al., 2006; Rothenberg et al., 2008)]. However, “absolute” levels of
expression measured relative to standards could vary over time
according to detailed conditions of measurement, with the worst
differences (5–10 fold) associated with certain primer sets. Thus all
analyses shown are based on simultaneous measurements across a
full series of samples, and patterns with little variance cannot be
accurately distinguished.
Clustering algorithms
Correlation values between the expression proﬁles of all genes in a
data set were calculated for each Series, and theywere post-processed
by sorting on Hierarchical (tree)(Baldi and Brunak, 2001) or Minimum
Spanning Tree (MST) algorithms as described in Supplementary
Methods. The values from qPCR analyses used were log transforma-
tions of averages of the two independent sets of data. Data from Series
A and from Series B were analyzed separately.
A method of visual representation of the correlation data was
developed as a matrix of the Pearson correlation values between
expression patterns of each gene with those of each other gene. In this
matrix, each value of entry ‘ij’ (row i, column j) reports the correlation
between expression of gene ‘i’ and gene ‘j’, while ‘ji’ would show the
correlation between the same two genes across a 45 angle of
reﬂection. For 60 genes processed, e.g., there are 60 entries per gene
with a value of 1 for each self-correlation, with these self-correlations
marking the diagonal of the matrix. A grid of values relating to colorsfrom blue to red were assigned: blue representing a maximum
correlation of +1, yellow a lack of correlation, and red a complete
anticorrelation at −1. This representation was applied to the genes in
lists ordered either by hierarchically clustered sorting (shown) or by
minimum spanning tree sorting (not shown). In the hierarchically
sorted coldmap clusters, the red numbers above the dendrogram
denoted the chronological order of the links drawn, with low numbers
for links between genes or groups of genes with very similar
expression patterns and high numbers between groups of genes
with more distinct expression patterns. Cluster or branch-cutting was
based on these link-orders.
The minimum spanning tree (MST) algorithm comes from the
cluster analyses of Xu and Olman (Olman et al., 2003; Xu et al., 2002);
where points are ordered so that the sum of their linkages is
minimized. This provides a way to view the data as a fully-connected
graph with the data points as the vertexes and the distances as the
edges. A tree can be obtained from this graph, such that each vertex is
visited once and the sum of the edges is minimal. Details of the
algorithms used for MST and hierarchical clustering are presented in
the Supplementary Material.
To visualize the patterns represented by each cluster as well as
their relationships, Self-Organizing Matrix (SOM) analysis (Tamayo et
al., 1999) was also applied to the data for each Series separately. Log-
transformed expression measurements for each gene across the DN
subsets were normalized to a row mean of 0 and then organized into
10–12 clusters by GeneCluster2 software (http://www.broad.mit.edu/
cancer/software/genecluster2/), using two-row and three-row orga-
nizations. The conﬁgurations presented explain N84% of the gene
expression variance in each Series.
Results
A. global search for transcription factor genes expressed in early
T-lineage cells
Most factors currently known to play a role in early T-cell
development have been discovered indirectly, either by serendipity
or by cis-regulatory analysis of genes expressed by mature T cells. To
search more broadly for transcription factors or transcription factor
variants that act during early T-cell development, we took a gene
discovery approach based on de novo cloning.
As a source enriched for cDNAs expressed during the choice of a
T-lineage fate, we used a macroarray of two cDNA libraries prepared
from immature thymic cells whose development beyond the point
of commitment was blocked by a “severe combined immune
deﬁciency” (scid) mutation in the Prkdc gene (Anderson et al.,
1999). These populations are ∼102 fold enriched, relative to normal
thymus, for immature T-lineage cells in stages between entry into
the thymus and commitment (Fig. 1A). This master arrayed library
has been a valuable source of stage-speciﬁc cDNA clones for
previous studies (Anderson et al., 1999; Chen et al., 2001; Tydell
et al., 2007). To recover candidate transcription factor coding
sequences, we screened ﬁlters spotted with the arrayed library
iteratively by hybridization with speciﬁc probes for diverse
transcription factor domains. Probes were made to detect canonical
DNA binding domain types or protein–protein interaction domain
types (Table 1), as described in Materials and methods. Clones
signiﬁcantly reactive with these probes were recovered from the
arrayed archive and sequenced. Sequences predicted to encode
regulatory factors, chromatin modifying proteins, and potentially
relevant signaling molecules were submitted to GenBank as
summarized in Table 2. Diverse splice isoforms of known genes
(e.g. Tfdp1, Rbak, and Zfp426) and many genes predicted to encode
transcriptional repressors (KRAB and SCAN domain Krüppel-type
zinc ﬁnger proteins) were identiﬁed from the SCID thymus cDNA
library.
Fig. 1. Landmarks for early T-cell lineage development. (A) Diagram of stages of early T-cell development. (B) Expression of T-cell differentiation genes at successive stages of T-cell
development. Samples are from “Series B”, except that Il2rb and Il7ra are shown for samples from Series A. For primer sequences, see Table 3 and (Taghon et al., 2007; Franco et al.,
2006). Values shown are geometric means of expression levels from the two component sets within the Series. Error bars: range. Gene expression levels are reported in units relative
to β-actin measured in the same samples.
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puriﬁed immature thymocytes from wildtype mice by qPCR, together
with expression of known T-lineage differentiation genes and
previously identiﬁed T-lineage transcription factors, as described in
the following sections.
Stages of developmental activation of T-cell genes
Cells in the ﬁrst stages of T-cell development that enter the thymus
are diagrammed in Fig. 1A. These stages are deﬁned as “double
negative” (DN), as they lack mature T-cell markers CD4 and CD8. In
order of maturity, these stages are termed DN1 (or early T-cell
precursor, ETP), DN2, DN3a, DN3b, and DN4. Progression through
these stages is profoundly dependent on Notch/Delta signaling. Yet
the maturation process is independent of the T-cell receptor (TCR)
until after the DN3a stage. At that point the cells arrest at a
developmental checkpoint and cannot proceed further until success-
ful rearrangement of TCR gene segments occurs. This conditional
arrest point is known as the “β-selection checkpoint”. During the
initial stages of intrathymic development, T-cell precursors retain
certain alternative developmental potentials. Precursors may develop
along natural-killer and/or dendritic cell lineage pathways. However,
by the DN3a stage, the cells are committed to some form of T-cell fate.
Because T-lineage differentiation occurs continuously in mammals
throughout life beginning at mid-gestation, the normal thymus is in a
dynamic steady state in vivo. To obtain a virtual timecourse of early T-
cell development for gene expression analysis, we sorted different
subsets of immature mouse thymocytes from postnatal, weanling
mice, deﬁning developmental stages based on expression of the
growth factor receptor c-Kit and markers CD44, CD25 (Ceredig and
Rolink, 2002), and where appropriate, heat-stable antigen (CD24) and
CD27 (Taghon et al., 2006). Four independent series of samples were
prepared from normal, young adult mice. DN1, DN2, total DN3, and
DN4 cells were collected in each of the ﬁrst two sets (“sets 1 and 2”,
Series A), whereas in the second two sets (“sets 4 and 5”, Series B) theDN3 cells were further subdivided into DN3a (pre-selection) and
DN3b (the ﬁrst stage past β-selection).
The timing of major positive regulatory changes that confer T-
lineage identity was revealed by expression of known T-cell
differentiation genes, such as those encoding TCR/pre-TCR complex
components CD3ɛ and CD3γ, kinases Lck and ZAP70, the speciﬁc
linker LAT, and the surrogate TCR chain Ptcra, as shown in Fig. 1B. All
these genes undergo substantial increases in expression from DN1 to
DN2 to DN3 or DN3a stage, with only ZAP70 expression continuing to
increase further beyond the DN3a stage. The most strictly T-lineage-
speciﬁc of these genes, CD3ɛ, CD3γ, and Ptcra, show a particularly
steep upregulation between the DN1 and DN2 stages. In correspond-
ing subsets of fetal thymocytes, the major increase in expression of
each T-lineage gene occurred similarly from the DN1 to the DN3 stage.
One minor difference was that the DN1 populations in those rapidly-
developing cohorts appeared to show slightly higher T-lineage gene
expression than adult DN1 stage cells (David-Fung et al., 2006)(M.A.
Yui, data not shown). Because Notch signaling is critical for T-cell
speciﬁcation, the samples were also assayed for expression of the
Notch target gene Deltex1 (Dtx1). Deltex1 is clearly upregulated in DN1
stage cells as compared to prethymic precursors (Tydell et al., 2007)
and is further upregulated during the DN2 to DN3 transition. Its
pattern of upregulation, however, fails to parallel the T-lineage-
speciﬁc genes in their initial increase from DN1 to DN2 (Fig. 1B). Thus
additional regulatory inputs besides Notch signaling are likely to be
needed to set the timing for upregulation of T-lineage genes.
Deﬁnition of the regulatory gene set
The regulatory factor set that we assembled for expression analysis
included the new candidate genes and about 20 additional transcrip-
tion factor genes already implicated in T-cell speciﬁcation by direct
genetic or biochemical evidence (Rothenberg et al., 2008; Anderson,
2006; Murre, 2005; Rothenberg and Taghon, 2005; Staal et al., 2001).
The total set of genes assayed is listed in Table 3. Genes encoding
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tion factors were included in the set as well, because they might
contribute partially redundant or competitive activities.
Many of the newly identiﬁed candidates encoded zinc ﬁnger
factors, often for which little annotation is available. These included
both Krüppel-type C2H2 zinc ﬁnger factors, likely to bindDNAdirectly,
and RING ﬁnger factors, likely to mediate ubiquitin E3 ligase functions
and/or other protein–protein interaction functions. Several Krüppel-
type zinc ﬁnger factors were predicted to be obligate repressors, based
on the presence of KRAB and/or SCAN domains in their sequences
(Collins et al., 2001), e.g. Rbak, Zfp1, Zfp28, Zfp109, Zfp110, Zfp287,
Zfp316, Zfp382, Zfp426, Zkscan1, Zkscan5, Zscan21, and Zscan22. Four
transcripts encoded Zn ﬁnger factors with BTB domains, i.e. Lrf
(Zbtb7a), Zbtb20, Zbtb48, and Zfp238.
Other genes were expected to encode transcriptional modiﬁers
that work without direct DNA binding (prothymosin α=Ptma), or
contribute to chromatin remodeling (Jmjd3, Myst3, Mta2, Mta3,
NCoR1, NCoR2, and SBF1) either to activate or to repress gene
expression. Some genes encoded members of known transcription
factor families that had not individually been implicated in T-cell
development before, such as the POU-homeodomain factor Pou6f1
(Brn-5) and the Ikaros relative Eos (Ikzf4). Transcripts encoding novel
isoforms of Rbak, Zfp426, and the winged-helix transcription factor
TfDp1, were also identiﬁed and later speciﬁcally assayed, although
these did not reveal a different pattern from the expression of the
canonical forms.
These novel regulatory candidates were monitored in parallel with
the known essential factors (Rothenberg and Taghon 2005) E2A
(Tcfe2a) and its partially redundant relative HEB (Tcf12), GATA-3
(Gata3), Gﬁ-1, TCF-1 (Tcf7), Ikaros (Ikzf1), Myb, Runx1,and PU.1 (Sfpi1),
and their relatives GATA-2, Gﬁ1b, LEF-1,Mybl2, Runx2, Runx3, and Spi-
B. We monitored Ets1 and Ets2, which may be implicated in TCR gene
expression, and other Ets familymembers associatedwith stem-cell, T-
cell, or NK cell function. Also analyzed were other members of the
Ikaros family and members of the helix–loop–helix inhibitor (Id)
family. As landmarks for differentiation in the same samples, we
assayed genes encoding the T-cell receptor signaling component CD3ɛ;
the Notch target gene Deltex1; and the growth factor receptors IL-7Rα
(CD127), IL-2Rβ (CD122), and GM-CSF-Rα (Csf2ra) to track changes in
the responsiveness of the cells to different environmental signals (Fig.
1B and data not shown). In all, 80 different candidate regulatory genes
were assayed in sets 1 and 2 (series A), and 56 candidate regulatory
geneswere assayed in sets 4 and5 (series B). In a review (David-Funget
al., 2006)we previously described a subset of the data fromseries B, for
19 genes, which is also included in this analysis for context.
The great majority of the regulatory genes were detectably
expressed in at least one developmental stage at levels that were
calculated to be above 10−2 times β-actin copy number. For cells with
the overall RNA content of immature thymocytes (∼1 pg/cell), this is
consistent with a lower boundary of about 3×10−3 times β-actin level
as the threshold for expression of at least one copy per cell in the
population. The comparability of series A and series B was checked by
assaying 13 transcription factor genes with important functions or
well-marked, distinctive expression patterns in both series: these
genes encoded Ets1, Ets2, FOG-1 (Zfpm1), GATA-3 (Gata3), HEB (Tcf12),
Id2, LEF-1, Pou6f1, PU.1 (Sfpi1), Runx1, Runx3, SpiB, and TCF-1 (Tcf7). In
general, there was excellent agreement between the overall patterns
of expression measured across the developmental stages. Also, for
more than half of these genes therewas also excellent agreement with
the absolute measured expression levels (within a factor of 2 or less).
Expression of landmark transcription factor genes and new candidates in
normal early T-cell development
Figs. 2–4 present analyses of the expression patterns of the
regulatory genes we monitored in the immature DN T-lineage cells ofseries A and series B. In Fig. 2, actual qPCR results for the genes are
shown with genes in alphabetical order. Data from Series A samples
are joined by solid curves, data from Series B samples by broken-line
curves. All the expression levels measured in Fig. 2 are presented in
units relative to β-actin in the same samples. Several methods were
used to group these regulatory genes based on their patterns of
expression during T-cell speciﬁcation. Fig. 3 shows the correlations
between expression patterns of different genes within series A and
series B. Here, genes are listed in an order determined by hierarchical
clustering (shown left of y axis), and the plot uses a color scale (“cold
map”) to show pairwise correlations between expression patterns of
each gene (y axis) with those of every other gene (x axis). Gene
expression patterns were also organized by the Minimum Spanning
Tree method of Xu et al. (2002), which discerned similar groups (G.
Buzi, data not shown). Finally, Figs. 4A, B show representative self-
organizing matrix (SOM) clusterings of the normalized expression
patterns for genes analyzed in each series (membership of clusters
listed in Supplementary Table 1). The boundaries between clusters are
somewhat ﬂexible, but Figs. 4C–F show actual expression levels of
genes that typify common patterns or features of regulatory factor
expression: “rising”, “declining”, “DN3 peak”, and “legacy and loss”.
Genes with minimally changing RNA expression: legacy genes
Each clustering method showed that the majority of genes we
monitored were expressed in a sustained, minimally changing (b3
fold) pattern fromDN1 to DN3 stage. This inter-correlated group is the
most dominant feature shown in Fig. 3 (especially 3A), and
encompasses not only the genes with “legacy” patterns shown in
Fig. 4F but also many genes not shown in Fig. 4 and genes with very
low amplitude DN3 peaks in Fig. 4E. Although many of these stably
expressed genes are poorly characterized, it must be emphasized that
this group also includes many of the factors known to be essential for
T-lineage speciﬁcation from genetic evidence. It includes Myb, MLL1,
Ikaros (Ikzf1), Gﬁ-1, GABPα, Stat5b, Oct1 (Pou2f1), and TOX, all of
which have critical roles in T-cell development and/or in T-cell
differentiation gene expression [rev. in (Rothenberg et al., 2008;
Rothenberg and Taghon, 2005) (Aliahmad and Kaye, 2008; Yao et al.,
2006; Ernst et al., 2004; Xue et al., 2004; Wilkinson et al., 2002; Chen
and Kuo, 2001; Ullman et al., 1990)]. The stably expressed group
contains at least as many known contributors toT-cell development as
the group of genes that are sharply upregulated (next section).
Furthermore, in terms of the provision of regulatory inputs for other
genes in the T-lineage program, genes such as FOG-1 (Zfpm1), Gse1,
Yy1, and Zfp598 contribute stably as well, which show slightly
different expression trends from most “legacy genes” (Supplementary
Table 1) but with very small changes in amplitude. The prevalence of
regulatory or candidate regulatory genes showing stable expression in
early T-cell development contrasted remarkably with the massive
changes in T-lineage gene expression and developmental potential
that occur across this interval (cf. Fig. 1B).
Upregulated genes
A surprisingly small group of genes showed deﬁnite upregulation
(Fig. 4C) during DN1 to DN3 progression. Most of the regulatory genes
in this group were previously known to be involved in T-cell
speciﬁcation, i.e., Gata3, Ets1 and Ets2, Tcf12, Tcf7, Lef1, Satb1, Ikzf3
(Aiolos), and Id3. Of the less-studied factors added to this group, Cutl1,
Hmga1, Jmjd3, Mlf2, Mybl2, Pou6f1, Ptma, and Zfp382 also appeared to
increase in expression with the onset of lineage-speciﬁc gene
expression. However, most of these upregulated factors increased
relatively little across the DN1 to DN3 progression, with gross
increases of b10-fold. Some of them peaked at DN3 and decreased
again after β-selection (DN3b and DN4), a pattern feature discussed
further below, for an even weaker net increase.
Within the “rising” group, the timing of upregulation of different
sets of regulatory genes deﬁned at least three different positive
Fig. 2. Regulatory gene expression patterns through early T cell development. Gene expression levels are shown for the putative regulatory genes in this study, arranged alphabetically in order of gene names. Gene expression levels are
measured by qPCR using primers shown in Table 3, and the geometric means of values determined from the two independent sets within each series are plotted on a log10 scale relative to the expression of β-actin in the same samples
(0= log101=level of β-actin). Data from both “Series A” and “Series B” are combined in these graphs, with Series A measurements joined by continuous line spline curves and Series B measurements joined by broken-line spline curves. One
group of Series B measurements that were determined separately from all the others is indicated by dotted curves (Mitf, Sox4, Bcl11a, Cebpa, and one set of Zfpm1). Where the same genes were analyzed in both series, both sets of values are
shown. In some cases (SpiB-1, SpiB-2; LRF, LRF⁎), the same genes are assayed with different primer sets. LRF⁎=primers fromMaeda et al. (Maeda et al., 2007). GATA-3-r=GATA-3 reassayed on the same Series B samples with the same primers,
but by a different investigator N1 yr after initial Series B measurement (David-Fung et al., 2006); included to show reproducibility. To align the Series A samples (DN1, 2, 3, and 4) with the Series B samples (DN1, 2, 3a, 3b, and 4), values were
plotted on an x/y plot inwhich DN1 was considered “1”; DN2 was considered “2”; DN3awas considered “3.0”; DN3bwas considered “3.7”; DN3 (unseparated), which is mostly DN3a, was considered “3.2”; and DN4 was considered to be “4.5”.
Thus, the β-selection checkpoint is represented by “3.5”. The same convention is followed in Figs. 4C–F and Fig. 6 as well.
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Fig. 3.Hierarchical clustering of putative regulatory genes based on pairwise correlations. (A) Genes tracked in Series A. (B) Genes tracked in Series B. “Coldmaps” are shown to depict
the correlation among gene expression patterns within each series, with blue representing full correlation and red representing full anticorrelation as described in Materials and
Methods. All genes analyzed in each series are listed in the same order along both the y axis and the x axis of each plot, with the origin at the upper left, so that the diagonal represents
the perfect correlations of each gene's expression patternwith itself. The order of the genes on each axis is set by hierarchical clustering of expression patterns as shown at the left of
each matrix, with red numbers indicating the closeness of relationship (low numbers: close; high numbers: remote; see Supplementary Methods). Note that in this hierarchical
clustering order, the clusters drawn should be considered to have rotational symmetry. Blocks of color help to visualize genes that are regulated in parallel (blue blocks) or in
signiﬁcantly opposing ways (orange/red blocks) through early T-cell development. Three major groups of genes with decreasing, sustained (“legacy”), and increasing expression are
identiﬁed with lines over particular blocks in Panel A. Series B was used in a targeted way to assaymany genes known from sources other than this gene discovery study, and so panel
B is more biased toward genes with diverse, highly inﬂected expression patterns.
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458 E.-S. David-Fung et al. / Developmental Biology 325 (2009) 444–467regulatory events. First, HEBalt (a promoter-use variant of Tcf12 (Wang
et al., 2006)) and Bcl11b underwent the most dramatic portion of their
upregulation at the DN1 to DN2 transition, as described elsewhere
(Tydell et al., 2007). At the next transition, fromDN2 to DN3, Ets2, Lef1,
and Pou6f1 were sharply upregulated, apparently in parallel. Then,
from DN3 to DN4 stage, Ikzf3 and Tbx21 were upregulated. Id3
appeared unique in its induction in early DN3 stage (DN3a) to a peak
in newly-selected DN3 cells (DN3b), followed by a striking decline in
the DN4 stage. The distinctive pattern seen for Id3 could reﬂect its
preferential use in the TCRγδ lineage (Taghon et al., 2006). These
results, in accord with some previously reported data (David-Fung et
al., 2006; Rothenberg et al., 2008; Taghon et al., 2006; Tabrizifard et
al., 2004; Morgan et al., 1997), emphasize that T-lineage speciﬁcation
occurs in an ordered cascade.
Genes downregulated during speciﬁcation
A prominent feature of the DN1 to DN3 progression was the
downregulation of hematopoietic transcription factor genes Gﬁ1b,
Gata2, Bcl11a, and of genes encoding several members of the Ets,
Helix–loop–helix, C/EBP, and Runx transcription factor families. Many
of these downregulated genes (Sfpi1 (PU.1), Tal1 (SCL), Id2, Cebpa, and
Bcl11a) are functionally implicated in non-T cell hematopoietic
differentiation programs (Herblot et al., 2000; Ikawa et al., 2001;
Anderson et al., 2002b; Liu et al., 2003; Lefebvre et al., 2005; Laiosa et
al., 2006). Another “declining” gene, Erg, was previously identiﬁed
(Anderson, 2006; Anderson et al., 1999) and has recently been
determined to be crucial for stem-cell maintenance (Loughran et al.,
2008). Genes encoding many factors not previously associated with
early T-cell precursors also fell into this group, e.g. Aff3, Elk3, Etv6,Fig. 4. Clusters of genes deﬁned by expression patterns and pattern elements. (A, B) Self-org
Numbers of clusters and 2-row orientations were chosen to account for at least 84% of the ov
in the cluster are indicated at the top of each panel. Names ofmembers of each of the clusters
showing an increase from DN1 to DN3 of N3 fold. Data extracted from Fig. 2. (D) Genes in this
a major peak in expression at DN3 (DN3a) followed by a substantial decline. (F) Examples o
substantial decreases at β-selection. Note that distinctions between the groups in (C)–(F) are
may appear more appropriate for different categories when different primers are used (SpiB
ambiguous cases the same gene data are shown in two panels to illustrate different pattern
comes from other independent measurements (Rothenberg et al., 2008; Taghon et al., 2006Klf2, Lima1, Rnf149, Tsc22d1, and Zfp316 (possibly also Thrap3).
Downregulation of these factors again occurred in distinct stages.
Some transcripts diminished mostly between the DN1 and DN2 stage,
including Tsc22d1, Lima1, Gata2, Cebpa and Cebpb, while others fell
most abruptly only after the DN2 stage (e.g., Tal1, Sfpi1, Gﬁ1b, Runx2
and Runx3, and Elk3). The most dramatic shutoffs of gene expression
were seen for PU.1 (Sfpi1) and SCL (Tal1), which fell at least two orders
of magnitude by the DN3 stage.
Multigene downregulation after the DN3 stage
The DN3 stage is when T-lineage commitment ﬁrst appears to be
complete, when proliferation stops, and when survival ﬁrst becomes
dependent on TCR signaling (β-selection). We expected most
discontinuities to occur between DN2 and DN3, with the T-cell
identity stabilizing thereafter. However, a more commonly observed
pattern element was a rapid decline in expression after the DN3 stage.
This was seen both for genes that had been stably expressed from the
DN1 stage (Fig. 4F) and for some genes that were newly upregulated at
the DN2 to DN3 transition (Fig. 4E). Downregulation ranged from a
slight decrease for some genes to virtual extinction of others. The
Notch-induced gene Deltex1 and the PU.1 relative SpiB showed abrupt,
transient peaks of expression at the DN3/3a stage followed by a sharp
decline (Fig. 4E). Other genes were downregulated sharply after more
gradually reaching the high point in DN3/DN3a cells. These included
Runx1, Zfp287, and the Ikaros family member Ikzf4 (Eos), as well as
Hes1 and HEBalt, which were also reported previously (Wang et al.,
2006; Tan et al., 2005; Yui and Rothenberg, 2004). Even among genes
that were also downregulated between the DN1 and DN3 stages,
Zbtb20, Klf2, Runx2, and even Id2 all showed their steepestanizing matrices of expression patterns of genes assayed in Series A (A) and Series B (B).
erall variance of gene expression in each Series. Cluster number (c) and number of genes
are listed in Supplementary Table 1; examples are shown in (C–F). (C) Genes in this study
study showing a decrease fromDN1 to DN3 of N3 fold. (E) Genes with patterns featuring
f genes showing steady “legacy” expression from DN1 to DN3, including all those with
not clearcut. Certain genes, e.g. SpiB and Id2, have a “legacy” element of expression but
-1 vs. SpiB-2, DN3 peak) or in different sample series (Id2, declining). In some of these
features, e.g. Id2, Zfp110 and Zfp287). Additional evidence for these pattern groupings
; Yui and Rothenberg, 2004).
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Fig. 5. Gene expression in thymocyte subpopulations with a genetic block to β-
selection: early T vs. NK lineage gene expression. Realtime qPCR measurements are
shown for subpopulations of thymocytes from B6.Rag2−/− mice, sorted as described
previously (David-Fung et al., 2006; Anderson et al., 2002b;Wang et al., 1998). True DN1
cells are very rare in these thymus populations, but the Sca-1+ Thy-1low subset contains
T-lineage precursor activity while pre-NK cells (Sca-1− Thy-1+/− CD24−) are marked by
strong perforin expression (David-Fung et al., 2006). Note distinctively high Tbx21 and
Il2rb expression in the pre-NK cells.
Fig. 6. Differential regulation of different members of the same transcription factor families
Ikaros family members, and (D) for genes predicted to encode KRAB and SCAN domain-con
460 E.-S. David-Fung et al. / Developmental Biology 325 (2009) 444–467downregulation after β-selection. The shutoff of expression after the
DN3a stage was the most conspicuous feature of the expression
pattern for the Ets-family gene Erg. In the cases of SpiB, HEBalt, and
Erg, at least, this downregulation appears to be permanent (see below)
(Rothenberg et al., 2008; Anderson et al., 1999). These results suggest
that although developmental commitment appears to occur at the
DN3 stage before selection, many “legacy” regulatory genes are shut
off only afterwards, apparently triggered by β- or γδ-selection.
Genes speciﬁcally expressed in thymic natural killer cells
One regulatory gene, Tbx21 (T-bet), showed an apparently
anomalous pattern of expression in these analyses. Although it was
recovered from our macroarrayed SCID thymus library in multiple
clones, qPCR showed this gene to be expressed at very low levels in
the DN1–DN3 T-cell precursor stages, with most of its expression
beginning only as the cells progressed to DN4. Since there is no β-
selection in SCID thymocytes, this appears inconsistent with the
apparent high prevalence of Tbx21 transcripts in the SCID thymus
cDNA library. Fig. 5 shows that this is because Tbx21 is actually
expressed selectively in thymic natural killer (NK) cells, a population
that is highly enriched in SCID thymocytes (Telfer and Rothenberg,
2001; Anderson et al., 1999; Wang et al., 1998). As in normal DN
thymocytes, the immunodeﬁcient cells showed increasing Hes1
expression in DN2 and DN3 cells, a sharp rise in Ets2 expression in. Gene expression data, extracted from Fig. 2, are shown for: (A) Ets, (B) Runx, and (C)
taining zinc ﬁnger factors.
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expressed highly in a Rag-deﬁcient population that contains the
earliest T-cell precursors (Sca-1+ Thy-1low), decreasing in DN2 and
DN3 cells and in differentiating NK cells. By contrast, Tbx21 expression
was highly enriched in the pre-NK population, a subset which is also
marked by its very high expression of IL2rb (Fig. 5). High expression of
Tbx21 was also conﬁrmed in mature TCRγδ cells (see below), in
agreement with others (Yin et al., 2002).
Discordant or compensatory expression within transcription factor
families
Ets, Runx, Helix–loop–helix, and Ikaros family transcription factors
are all implicated in stage-speciﬁc T-cell development and gene
regulation. Our results, however, showed that these families are
continuously well-represented at all stages in early T-cell develop-
ment. It is the balance among family members that undergoes stage-
speciﬁc developmental change. Fig. 6 (extracted from the data in Fig.
2) shows detailed patterns of expression for transcription factors of
some of these families. Some of the strongest changes in expression
occur, in opposite directions, among different members of the same
structural families. Most dramatic are the expression patterns in the
Ets factor family. While PU.1 (Sfpi1) plunges, SpiB spikes and then falls;Fig. 7. Cell type speciﬁcity of gene expression induced in hematopoietic progenitors on OP9
day time points, starting frommultipotent c-Kit+ CD27+ Lin− hematopoietic precursors from
permit T-cell development (blue shaded bars), and on OP9-DL1 stroma, which promotes T-ce
cells. Cultures were harvested for RNA preparation every two days. At day 4, cells from the cul
repuriﬁed before being placed in fresh cultures for the remaining 2–6 days (Taghon et al., 20
an intermediate timepoint or were repuriﬁed at day 2 instead (data not shown). By 6 d, ∼5
culture are CD19+ (Taghon et al., 2005). Genes transiently induced on either stroma (e.g. Il2rb
then suppressed during sustained culture under OP9-control or OP9-DL1 conditions.and while Elk3, Etv6 (TEL), and Erg decrease, Ets1 and Ets2 increase
(Fig. 6A). Concomitantly, as Runx2 and Runx3 decrease, Runx1
increases (Fig. 6B). Ikaros family members Ikaros (Ikzf1) and Helios
(Ikzf2) are expressed fairly stably, but Aiolos (Ikzf3) dips and then rises
while Eos (Ikzf4) peaks and falls (Fig. 6C). Note also that even though
Lef1 and Pou6f1 are among the genes most sharply induced at the DN2
to DN3 transition, their respective relatives Tcf7 and Pou2f1 (Oct1) are
also being expressed in a more sustained pattern, at apparently higher
levels (cf. Fig. 2). The bHLH transcription factor families including SCL
and the E proteins are also highly dynamic, as are their inhibitors
(Wang et al., 2006) (cf. Fig. 2).
As many “new” KRAB and SCAN domain zinc ﬁnger coding genes
were identiﬁed in our screen, and are possible candidates for negative
regulatory components of the commitment mechanism, it was also of
interest to determine how these predicted repressors might be
regulated. As shown in Fig. 6D, these genes also showed a mixture
of expression patterns: many were expressed stably and at relatively
high levels, while others, including the SCAN domain factor Gﬁ1b,
were downregulated at the DN2–DN3 or later transitions. None of
those identiﬁed were substantially upregulated during speciﬁcation,
however.
Similar or identical target sequences are thought to be bound by
multiple members of the Ets, bHLH, Ikaros, Tcf/Lef, and Runx families.stroma. Gene expression levels are shown in units relative to β-actin at successive two-
fetal liver. Cells were cultured for up to ten days on OP9-control stroma, which does not
ll development (brown to yellow shaded bars). Black bars show gene expression in input
tures were collected and those retaining a precursor phenotype (c-Kit+ CD27+ Lin−) were
05). Similar results were obtained in experiments where the cells were not repuriﬁed at
0% of cells in OP9-DL1 culture are at least DN2 stage, and ∼30% of cells in OP9-control
, Cebpa) reﬂect abortive emergence of NK and myeloid cells (data not shown), which are
Table 4
Expression patterns beyond the pro-T cell stages
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Legend: (A) Deﬁnition of pattern types for genes analyzed in the study. Genes were classiﬁed according to their patterns of expression in the DN1–DN4 stages, based on their
expression in cluster analyses such as those in Fig. 4, with adjustment “by hand” to take into account whether the dynamic ranges of their proﬁles exceeded the range of inter-
experiment error, or whether they were essentially ﬂat in expression across these stages. Patterns are described at the foot of Table 4A. Dynamic range indications are as follows:
10=greater than tenfold range from peak to trough in DN stages; 3=between threefold and tenfold range; 1= less than threefold range. (B) Expression of genes in non-T
developmental contexts and in stages after β- or γδ-selection. Gene expression levels were assayed in 2 samples each of the following: bone marrow derived pre-myeloid cells; pro-
B cells, as CD19+ cells from Rag2−/− mouse bone marrow; Rag2−/− total thymocytes; TCRβ−/− total thymocytes; TCRγδ+ cells sorted from TCRβ−/− thymus; and sorted subsets from
wildtype thymocytes as follows: DN (mostly DN3 and DN4); DP (CD4+ CD8+); CD4 SP (TCR+ CD4+ CD8−); and CD8 SP (TCR+ CD4− CD8+). Data from individual samples were ﬁrst
normalized according to β-actin levels, then the geometric mean of independent samples was calculated. To compare patterns of use for genes that are expressed at very different
levels, all values were then normalized to a reference “pan-DN” level for each gene, that is the geometric mean of the values in Rag2−/−, TCRβ−/−, and sorted DN wildtype thymocytes.
The Table shows the resulting relative expression values. For genes that increase in expression after β-selection, the sorted DN sample value will be greater than 1; for genes that
decrease in expression from the DN1 stage through β-selection, the sorted DN sample value will be less than 1. Cells are shaded to help discern different patterns of expression:
orange shaded cells show expression that is more than 3× higher than the reference pan-DN value; green shaded cells show expression that is less than 30% of the level of the
reference pan-DN value; purple shaded cells show expression that is less than 1/10 of the level of the reference pan-DN value. Gray shaded cells have no data.
Table 4 (continued)
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the patterns of their RNAs, then these data imply that Ets, Runx, bHLH,
and Ikaros binding sites in target genes may be continuously occupied
throughout early T-cell development, but by shifting combinations of
factors within these families.
Lineage speciﬁcity and kinetics of induction in vitro
The evidence presented so far suggests that stage-speciﬁc positive
and negative regulatory changes during the DN1 to DN3 progression
are superimposed on a rich background of gene expression continuing
from the earliest stage through commitment. In this context, we
revisited the question of which regulatory genes in our studymight be
T lineage-speciﬁc. Not only genes upregulated during commitment
but also some of the genes with seemingly stable expression could be
candidates. Most cells in the earliest stage of adult mouse T-cell
development, the DN1 stage, have already been acted upon by the
thymic microenvironment and are already distinct from multilineageprethymic precursors, e.g. with respect to expression of Dtx1, Gata3,
Hes1, and Tcf7 (Heinzel et al., 2007; Sambandam et al., 2005; Tan et
al., 2005; Tydell et al., 2007). Thus we investigated whether the stable
expression of regulatory genes from DN1 to DN3 stage was actually
continuing from prethymic precursors or was an immediate response
to thymic signals. For this, we made use of an in vitro differentiation
system in which a cohort of prethymic precursors can be traced over
time as they enter the T-cell pathway (Schmitt et al., 2004b; Schmitt
and Zuniga-Pﬂucker, 2006; Taghon et al., 2005). The T-cell program is
triggered in hematopoietic progenitor cells by co-cultivation with
stromal cells that have been forced to express a Delta-type Notch
ligand. In the absence of the Notch ligand, or at reduced Notch
signaling intensity, these same stromal cells support differentiation
into B (and some NK) cells but not Tcells (Schmitt et al., 2004a). Thus a
comparison of the differentiation of the same precursor cells on
stromal cells with and without Delta reveals not only discontinuities
from prethymic input cells but also differences between the T and B-
cell programs.
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genes representative of each expression pattern. The gene expression
measurements from one well-characterized OP9 culture time course
(Taghon et al., 2005; Tydell et al., 2007) are shown in Fig. 7. Similar
results were obtained in a second timecourse of four days overall, and
in samples re-sorted from the two timecourses at two or four days of
culture (data not shown). B-cell speciﬁcation was tracked by
upregulation of the Pax5 gene. In these samples, the Notch target
gene Dtx1 and previously characterized T-cell speciﬁc regulatory
genes Gata3, Tcf7, and Bcl11b as well as the T lineage-speciﬁc
differentiation gene Cd3e were upregulated only under T-cell condi-
tions as previously reported (Taghon et al., 2005; Tydell et al., 2007).
Those data are included here again as a standard for T-lineage
speciﬁcity. None of the other genes in this study showed comparably
strong T-lineage speciﬁcity. A group of other genes did show a weaker
but detectable preference for T-cell conditions, with either accelerated
or more extensive upregulation. These genes included Ets2, Foxp4,
Myb, Rbak, Pou6f1, Satb1, Tcf12, and Tle3 (Fig. 7). In addition, “legacy
pattern” representatives Mta3 and Stat5b appeared to be sustained
better from stem-cell levels in the T-lineage conditions than in the B-
lineage conditions.
Even so, the great majority of the genes analyzed were not induced
preferentially during T-lineage differentiation under T-cell conditions.
Although genes such as HEBalt and Pou6f1 are markedly upregulated
in vivo at particular DN stages, they also were substantially induced in
the B-cell conditions. Of particular interest were the four regulatory
genes, Ets1, Ets2, Lef1, and Pou6f1, which are speciﬁcally induced
during commitment to the T-cell lineage at the DN3 (DN3a) stage and
maintained thereafter. If this event represents the deﬁnitive activation
of T-lineage speciﬁc regulators, then these genes should show clear T-
lineage speciﬁcity. Indeed, Ets2 showed an increasing expression
speciﬁcally in T-lineage promoting conditions. But as already noted,
Pou6f1 was clearly upregulated in B-cell precursors as well, and Ets1
and Lef1 showed no sustained T-lineage preference at all. SpiB, also
speciﬁcally upregulated during the DN3 stage, was expressed
considerably better in the B lineage cells.
These results are consistent with a separate assessment of the T-
lineage speciﬁcity of N70 of these genes, in which we compared
expression in adult DN pro-T cells with expression in freshly isolated
bone marrow myeloid cells and pro-B cells (Table 4B, columns 1–3).
This survey also included Cd3e, as a marker for T lineage speciﬁcity,
the B-lineage speciﬁcation gene Pax5, and Bcl6, which encodes a
factor crucial for mature B-cells and is reported to provide physiolo-
gical restraint on the expression of GATA-3 in peripheral T cells
(Kusam et al., 2003). The results conﬁrmed that the overwhelming
majority of the transcription factor genes assessed were not T lineage-
speciﬁc in expression. Of the genes analyzed in this series, only Gata3,
Tcf7, Pou6f1, Ets2, and TOX (not monitored in the OP9 culture samples)
showed an early T-lineage preference, i.e. with T-cell levels N3×
greater than their levels in myeloid and pro-B cells. SATB1 also nearly
met this criterion (Bcl11b was not assayed in these samples). Tbx21
was expressed more strongly in thymocytes than in myeloid or pro-B
cells, but on closer examination, it was strongly expressed only in
TCRγδ cells and in unsorted mutant thymocyte populations with a
strong NK component (sorted wildtype DN cell value b0.15 of pooled
“pan-DN” reference value). In this comparison as well as in Fig. 7, Table
4 conﬁrms that the levels of Ets1 and Lef1were no higher in pro-T cells
than in pro-B cells, in agreement with their known roles in B cell
development (Wang et al., 2005; Reya et al., 2000).
Taken together, these results show that the regulatory genes with
strongly T-lineage speciﬁc expression are a very select subset of pro-T
cell transcriptional regulators, and that within our sample they are
represented only by Gata3, Tcf7, TOX, and Bcl11b. These are all factors
that undergo most of their upregulation before the DN3 stage, i.e.
before T lineage commitment. But the notable result is thatmost of the
regulatory factors in our set that are speciﬁcally induced during thetransition to T lineage commitment appear to be factors with
substantial expression in the B-cell or myeloid lineages as well.
Roles in later T-cell development for factors used in pro-T cell
speciﬁcation
The downregulation during β-selection that was observed for
many of the new transcription factor genes raised the question of
whether factors sharing particular expression proﬁles during the pro-
T cell stages might also be used in parallel patterns in later stages of T-
cell development. Therefore, we also surveyed gene expression in a
collection of samples representing later, TCR+ stages of T-cell
development, from CD4+ CD8+ (double positive, DP) to mature CD4+
or CD8+ TCRαβ+ cells, and TCRγδ+ cells (Table 4B). In Table 4A, each
qualitative expression pattern as deﬁned in the DN cells (from Figs. 2–
4) is coded; then within each pattern, the genes are further classiﬁed
according to the overall magnitudes of their expression changes from
lowest to highest level, to distinguish weak and questionable
expression changes from strong ones. As for the non-T cell samples
in Table 4B, expression of each gene in TCR+ subsets is presented in
units relative to its expression in a pool of DN cell samples, and color
coded to help discern similar and different overall patterns of cell type
speciﬁcity. A number of the gene expression patterns shown here have
been corroborated in a separate analysis with independent sets of
samples (Rothenberg et al., 2008).
While this survey was too small to establish deﬁnitive expression
levels, Table 4B shows that genes representative of each DN pattern
could go on after β-selection to be expressed in diverse combinations
in each of these cell types. Not only genes with sharp ascending or
descending patterns, but also genes with “legacy” or “ﬂat” expression
patterns (Table 4, patterns 5 and 8) showed notably divergent patterns
of expression in TCR+ stages represented by DP, CD4 SP, CD8 SP, or
TCRγδ cells. As expected, progenitor-cell genes such as Sfpi1 that were
repressed during commitment were never re-expressed, but also an
additional group of genes (e.g. Erg, SpiB, Hes1, FUS, TfDp1, and Hmga1)
remained profoundly downregulated in all TCR+ cells, even though
they were shut off only at β-selection, considerably later than Sfpi1
(PU.1), Lima1, Tal1, and Gata2. Thus, a limited hit-and-run role during
the pro-T cell stages is suggested for at least two distinct sets of
regulatory genes. Other genes were downregulated selectively in CD4+
CD8+ DP cells, in all TCRαβ+ mature cells, or in CD4+ or CD8+ cells
speciﬁcally (Table 4B). Another, unanticipated ﬁnding was a group of
transcription factors that appear to distinguish sharply between
TCRγδ cells and any of the TCRαβ+ subsets. Period1, Stat5b, and Zbtb48
appeared to be downregulated in TCRγδ cells as compared to TCRαβ+
cells; Dmtf1 and NCoR2 were speciﬁcally elevated in TCRγδ thymo-
cytes, along with known TCRγδ-enriched factors Runx3 and Tbx21
(Taghon et al., 2006; Yin et al., 2002). Thus, transcription factors
inherited from prethymic precursors may still help to generate T-cell
functional diversity after the pro-T cell stages.
Discussion
T cell lineage choice appears to encompass two major regulatory
events: an asynchronous upregulation of increasing numbers of T-cell
genes from the DN1 to the DN3 stage, and a sharp discontinuity in
developmental potential when the cells undergo lineage commitment
during transition to the DN3 stage. These two processes are followed
by a TCR signal-dependent cascade of selective and developmental
changes through the β-selection transition. If T-cell development
followed the model of B-cell development, then the onset of T-lineage
gene expression should reﬂect the activity of T-lineage speciﬁc
transcription factors, and commitment to the T-cell lineage would
reﬂect the advent of the deﬁnitive T-cell speciﬁc regulatory state. In
this study, however, we see that the T-lineage commitment process
departs from expectation in several respects. First, the essential
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remain rare and do not seem to be upregulated during commitment.
Second, many of the regulatory changes that do occur in early T-cells
are to repress a subset of prethymically inherited genes rather than to
upregulate newT-cell speciﬁc factors, as notedbyothers (Kawazu et al.,
2007). Third, at the DN3 stage when commitment is thought to occur,
the regulatory genes turned on are mostly not T-lineage speciﬁc. This
suggests that the detectable evidence of commitment at this stagemay
be a readout of amore general cell biological function rather than a cell
type identity function as such. Finally, we show that the loss of factors
inherited from the prethymic, multipotent progenitor state may only
be completed during β-selection. The β-selection (or γδ-selection)
process may therefore contribute a larger aspect of the commitment
mechanism than has previously been recognized.
A few caveats need to be stated. First, our analysis is not a complete
accounting for all transcription factor genes. Although the gene
discovery methods we have used here and in related studies
(Anderson et al., 1999; Tydell et al., 2007) have expanded the pool
of known candidate regulatory molecules (and their splice isoforms)
in early pro-T cells, our gene lists should be considered as a
complement to those in microarray studies as in work by the groups
of Petrie, Staal, Ogawa, andMelchers (Tabrizifard et al., 2004; Dik et al.,
2005; Kawazu et al., 2007; Hoffmann et al., 2003). In contrast to this
study, most of the recent microarray studies cited have not addressed
how different patterns of expression might be related to lineage
speciﬁcity. Where our data overlap with these published reports, they
are in general agreement, but each kind of study includes genes that
are not highlighted in the other. A second caveat is that the RNA-
centered analyses used here almost certainly miss some levels of
regulation that alter protein levels between stages at which RNA levels
are constant. Known examples relevant to T-cell development are the
cases of E2A (Engel et al., 2001) and GATA-3 (Yamashita et al., 2005;
Kusam et al., 2003; Hernández-Hoyos et al., 2003), both of which
could be more sharply regulated between certain cellular states than
their transcript levels reveal. Nevertheless, even if we miss some
changes in active factor levels when RNA expression appears “ﬂat”,
when we do see major changes in RNA level, it is very likely that
protein activities are also changing.
This regulatory gene expression analysis sheds light both on the
cellular states that make up the stages of T-cell development and on
the status of the regulatory molecules that may promote transitions
between these stages. Considering these regulatory genes simply as
indicators, the gene expression patterns shown here increase greatly
the number of “dimensions” of data we have to distinguish DN1 from
DN2 from DN3 pro-T cells. Instead of relying only on c-Kit, CD44, and
CD25 to track normal developmental progress, the distinctively timed
downregulation patterns of PU.1 (Sfpi1), SCL (Tal1), Gﬁ1b, Erg, Zfp316,
Runx2 and Runx3, and Elk3 can also be used together with the
distinctively timed upregulation patterns of Bcl11b, Ets2, Lef1, Id3, and
Pou6f1 to provide a much ﬁner-grained picture of normal or abnormal
developmental progression. The downregulation at β-selection that
normally affects Hes1, SpiB, Erg, HEBalt, and genes like Zbtb20 and
Zfp287 can also be used to diagnose abnormalities of passage through
this checkpoint (Yui and Rothenberg, 2004). Consideration of this
expanded set of stage markers reveals reproducible variations of
normal T cell development, as between the normal adult pathway and
the accelerated development in the fetal thymus (David-Fung et al.,
2006). In this case, because the “stage markers” actually encode
regulatory factors, the differences may eventually shed light on the
mechanisms controlling the differing rates of fetal and adult
development.
The products of these regulatory genes also need to be considered
as “drivers”. Changes in gene expression from stage to stage ultimately
arise from changes in transcription factor activity. However, the often-
subtle changes in expression of known essential regulators that we
report raise important questions about the amount and type of changethat is needed to be signiﬁcant. Transcription factors work combina-
torially in order to regulate target genes, and even factors showing
minimal change can be functionally important participants in the T-
cell developmental process through interaction with different part-
ners. Thus, not everything that is functionally important for activation
of a particular target gene needs to change in level. Among the factors
known to be critical for T-cell speciﬁcation (Rothenberg and Taghon,
2005; Anderson, 2006), some like Myb and Gﬁ1 may increase less
than three- to ﬁve-fold between the stem cell state and the committed
DN3 stage (Tydell et al., 2007; Rothenberg et al., 2008). These
precedents suggest that “legacy” factors generally could also be
potential participants in T-lineage speciﬁcation, changing their
functions through interaction with different partners (Sieweke and
Graf, 1998).
Our results also suggest that what turns on different genes at
different stages of the T-cell development process is sometimes not so
much the appearance of a new transcription factor DNA-binding
activity, but rather, the change in the identity of the dominant
transcription factor that can bind to a given DNA regulatory site. As we
show here, the overall level of DNA binding activity by Ets, Runx, and
Ikaros family factors may be virtually constant from DN1 to DN3 stage.
It is mainly the balance among different members of the family that
undergoes dramatic developmental change. Clearly some of these
families can participate in causing these changes through their own
cross-regulatory relationships: Gﬁ1b repressing Gﬁ1, Runx3 repres-
sing Runx1, and PU.1 repressing SpiB, Ets1, and Ets2 (Doan et al., 2004;
Vassen et al., 2005; Spender et al., 2005; Franco et al., 2006). But for
the change among family members to make a difference, it is likely
that protein–protein interactions with other transcription factors are
affected by the swap of one family member for another, and not just
simple afﬁnity for a DNA target site: there are clear precedents for this
among Ikaros family factors (Thompson et al., 2007). By extension,
each of the members of these families may compete with the others
functionally. For example, as the cells progress from DN1 to DN3,
downregulation of Runx2, Runx3 and Gﬁ1b could greatly enhance the
impacts of the slight upregulation of Runx1 and Gﬁ1, on target genes
for which these family members are not functionally equivalent.
There are two crucial watersheds in the T-cell speciﬁcation process
that need to be explained in regulatory terms, and our results shed
light on what they actually entail. These are, ﬁrst, the onset of T-
lineage gene expression from DN1 to DN2, while the cells are
apparently still multipotent, and second, the loss of multipotency as
the cells reach the DN3 stage. This work and previous data (Tabrizifard
et al., 2004; Dik et al., 2005; Tydell et al., 2007) show that the DN1 to
DN2 transition involves only modest increases in expression of two T-
lineage speciﬁc regulators (GATA-3 and TCF-1) and the dramatic
upregulation of a third, Bcl11b. But although our gene discovery
strategy has yielded many “new” potential transcriptional regulators
in early T-lineage cells, no new candidates are both T-cell speciﬁc and
signiﬁcantly upregulated at this time. This conclusion is also
supported by published microarray data (Dik et al., 2005; Tabrizifard
et al., 2004; Hoffmann et al., 2003). Could GATA-3 or TCF-1 be the
main driver of T-cell gene activation at the DN2 stage? This seems
questionable because the major upregulation of these factors occurs
much earlier, in entry to the DN1 stage (Tydell et al., 2007), which can
be multiple rounds of proliferation before the DN2 stage (Petrie and
Zuniga-Pﬂucker, 2007). Notch inputs seem to be needed throughout,
and there is little indication from Hes1 or Dtx1 expression that there is
any special intensiﬁcation of Notch signaling at this point [rev. in
(Rothenberg et al., 2008)]. Bcl11b is of great interest, but seemingly is
not required for development even to the DN3 stage (Inoue et al.,
2006). While Gﬁ1 and E protein genes are somewhat upregulated,
they are not T-lineage speciﬁc. Therefore, a major timing element in
this initial phase of speciﬁcation may be an increased permissiveness
for the activity of T-lineage speciﬁc genes through the downregulation
of multiple DN1 and prethymic regulatory genes. It may indeed be
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factors like E2A to undergo sudden gains in potency, e.g. by post-
transcriptional mechanisms, during the DN1 to DN2 transition (Engel
et al., 2001).
The results also imply that the commitment process itself has a
compound nature that is masked in conventional comparisons
between DN2 and DN3 cell potential. Negative regulation of Gﬁ1b,
SCL, PU.1, and other factors should play a role. But the surprise is that
the factors speciﬁcally upregulated during commitment are almost all
shared between the T lineage and other cell types, with little if any
preferential expression in T cells as opposed to B cells. Ets2
upregulation and the transient hyperactivation of Notch pathway
target genes are the twomainpositive events that are T lineage-biased;
but the Notch activation is not a stable change and the Ets2 activity
appears to remain low compared to its pan-lymphoid relative Ets1.
Ets2may have a later speciﬁc role inTcell development (Zaldumbide et
al., 2002), as our OP9 time course captures only the beginning of its
upregulation (M.A.Y., data not shown), but its expression is not actually
T-lineage speciﬁc, as it is expressed in myeloid cells as well (Ross et al.,
1998). Thus the transition frommultipotent to committedmay not use
an exclusively T-lineage speciﬁc mechanism. Note that the DN3 stage
in adult mouse thymocytes is associated with a proliferative halt
(Petrie and Zuniga-Pﬂucker, 2007), with growth resuming only if β- or
γδ-selection is successful. Conceivably the change assayed as “com-
mitment” is primarily a loss of proliferation, before new functions are
conferred during the β-selection process. A permanent lockdown of
commitment might only be required to preserve lineage ﬁdelity if and
when proliferation might resume. Thus it is also notable that our
results show another major phase of repression during β-selection,
when a large subset of the “legacy” genes, which had been stably
expressed through the DN3 stage are ﬁnally turned off. In this altered
regulatory environment, the proliferation associated with β- and γδ-
selection would not only dilute out pre-existing transcription factor
proteins but also provide opportunities to remodel chromatin, which
would not be available in G1 arrest in the DN3 stage. Thus it may be
only through β- or γδ-selection that commitment can actually be
converted into a stable and heritable condition.
In perspective, the induction of Tcf7 and Gata3 and then Bcl11b, all
in the earliest steps of T-cell development, remain the most T-lineage
speciﬁc of all the regulatory features studied here. Their initial
upregulation occurs in the stages when cells are still multipotent, and
our results show that few if any other T-lineage speciﬁc regulators are
likely to be added as the cells undergo lineage commitment. What
occurs instead appears to be the stripping away of other alternative
pathway regulators and neutralization of inhibitory inﬂuences, so that
a latent identity already instilled in the earliest intrathymic precursors
can be stabilized and revealed.
Acknowledgments
We are deeply indebted to Dr. Howard Petrie (Scripps Florida) for
valuable discussions during the gestation of this work and for
generous sharing of data prior to publication. We are also grateful to
Dr. Hamid Bolouri (Caltech and Institute for Systems Biology) and Dr.
Eric Davidson (Caltech) for insightful critiques, encouragement, and
advice. We also thank Brian Birditt and Scott Bloom (Institute for
Systems Biology) for their excellent work sequencing and identifying
the cDNA clones from our gene discovery; Marissa Morales and Dr.
Rashmi Pant, for key contributions to the gene expression measure-
ments and their validation; Dr. Tom Taghon, for generous collabora-
tion on making the samples for the OP9 experiments; Gillian Giorgio,
for early help curating the sequence ﬁles; Stephanie Adams of the
Caltech Flow Cytometry Facility, for outstanding help with the sorting;
and Robin Condie and Ruben Bayon for excellent care of the animals.
This work was undertaken with support from the Stowers Institute
for Medical Research and then supported by grants from the NSF(MCB9983129) and the NIH (R01 CA90233 and R33 HL089123), and by
the Louis A. Garﬁnkle Memorial Laboratory Fund, the Al Sherman
Fund, the Albert Billings Ruddock Professorship, and the DNA
Sequencer Royalty Fund at Caltech.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2008.10.021.
References
Adachi, S., Rothenberg, E.V., 2005. Cell-type-speciﬁc epigenetic marking of the IL2 gene
at a distal cis-regulatory region in competent, nontranscribing T-cells. Nucleic Acids
Res. 33, 3200–3210.
Aliahmad, P., Kaye, J., 2008. Development of all CD4 T lineages requires nuclear factor
TOX. J. Exp. Med. 205, 245–256.
Anderson, M.K., 2006. At the crossroads: diverse roles of early thymocyte transcrip-
tional regulators. Immunol. Rev. 209, 191–211.
Anderson, M.K., Hernandez-Hoyos, G., Diamond, R.A., Rothenberg, E.V., 1999. Precise
developmental regulation of Ets family transcription factors during speciﬁcation
and commitment to the T cell lineage. Development 126, 3131–3148.
Anderson, M.K., Hernandez-Hoyos, G., Dionne, C.J., Arias, A., Chen, D., Rothenberg, E.V.,
2002a. Deﬁnition of regulatory network elements for T-cell development by
perturbation analysis with PU.1 and GATA-3. Devel. Biol. 246, 103–121.
Anderson, M.K., Weiss, A., Hernandez-Hoyos, G., Dionne, C.J., Rothenberg, E.V., 2002b.
Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T-cell
development at the pro-T stage. Immunity 16, 285–296.
Anderson, M.K., Pant, R., Miracle, A.L., Sun, X., Luer, C.A., Walsh, C.J., Telfer, J.C.,
Litman, G.W., Rothenberg, E.V., 2004. Evolutionary origins of lymphocytes:
ensembles of T cell and B cell transcriptional regulators in a cartilaginous ﬁsh. J.
Immunol. 172, 5851–5860.
Baba, Y., Garrett, K.P., Kincade, P.W., 2005. Constitutively active b-catenin confers
multilineage differentiation potential on lymphoid and myeloid progenitors.
Immunity 23, 599–609.
Baldi, P., Brunak, S., 2001. Bioinformatics: The Machine Learning Approach. MIT Press,
Cambridge, MA, USA.
Ceredig, R., Rolink, T., 2002. A positive look at double-negative thymocytes. Nat. Rev.
Immunol. 2, 888–897.
Chen, M.-L., Kuo, C.-L., 2001. A conserved sequence block in themurine and humanTcell
receptor Ja loci interacts with developmentally regulated nucleoprotein complexes
in vitro and associates with GATA-3 and octamer-binding factors in vivo. Eur. J.
Immunol. 31, 1696–1705.
Chen, F., Rowen, L., Hood, L., Rothenberg, E.V., 2001. Differential transcriptional
regulation of individual TCR Vb segments before gene rearrangement. J. Immunol.
166, 1771–1780.
Cobaleda, C., Schebesta, A., Delogu, A., Busslinger, M., 2007. Pax5: the guardian of B cell
identity and function. Nat. Immunol. 8, 463–470.
Collins, T., Stone, J.R., Williams, A.J., 2001. All in the family: the BTB/POZ, KRAB, and
SCAN domains. Mol. Cell Biol. 21, 3609–3615.
David-Fung, E.S., Yui, M.A., Morales, M., Wang, H., Taghon, T., Diamond, R.A.,
Rothenberg, E.V., 2006. Progression of regulatory gene expression states in fetal
and adult pro-T cell development. Immunol. Rev. 209, 212–236.
Dik,W.A., Pike-Overzet, K.,Weerkamp, F., de Ridder, D., de Haas, E.F., Baert, M.R., van der,
S.P., Koster, E.E., Reinders, M.J., van Dongen, J.J., Langerak, A.W., Staal, F.J.T., 2005.
New insights on human T cell development by quantitative T cell receptor gene
rearrangement studies and gene expression proﬁling. J. Exp. Med. 201, 1715–1723.
Dionne, C.J., Tse, K.Y., Weiss, A.H., Franco, C.B., Wiest, D.L., Anderson, M.K., Rothenberg,
E.V., 2005. Subversion of T lineage commitment by PU.1 in a clonal cell line system.
Dev. Biol. 280, 448–466.
Doan, L.L., Porter, S.D., Duan, Z., Flubacher, M.M., Montoya, D., Tsichlis, P.N., Horwitz, M.,
Gilks, C.B., Grimes, H.L., 2004. Targeted transcriptional repression of Gﬁ1 by GFI1
and GFI1B in lymphoid cells. Nucleic Acids Res. 32, 2508–2519.
Engel, I., Johns, C., Bain, G., Rivera, R.R., Murre, C., 2001. Early thymocyte development is
regulated by modulation of E2A protein activity. J. Exp. Med. 194, 733–746.
Ernst, P., Fisher, J.K., Avery, W., Wade, S., Foy, D., Korsmeyer, S.J., 2004. Deﬁnitive
hematopoiesis requires the mixed-lineage leukemia gene. Dev. Cell 6, 437–443.
Franco, C.B., Scripture-Adams, D.D., Proekt, I., Taghon, T., Weiss, A.H., Yui, M.A.,
Adams, S.L., Diamond, R.A., Rothenberg, E.V., 2006. Notch/Delta signaling
constrains re-engineering of pro-T cells by PU.1. Proc. Natl. Acad. Sci. U. S. A.
103, 11993–11998.
Hagman, J., Lukin, K., 2006. Transcription factors drive B cell development. Curr. Opin.
Immunol. 18, 127–134.
Hattori, N., Kawamoto, H., Fujimoto, S., Kuno, K., Katsura, Y., 1996. Involvement of
transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell
development in the thymus. J. Exp. Med. 184, 1137–1147.
Heinzel, K., Benz, C., Martins, V.C., Haidl, I.D., Bleul, C.C., 2007. Bone marrow-derived
hemopoietic precursors commit to the T cell lineage only after arrival in the thymic
microenvironment. J. Immunol. 178, 858–868.
Herblot, S., Steff, A.M., Hugo, P., Aplan, P.D., Hoang, T., 2000. SCL and LMO1 alter
thymocyte differentiation: inhibition of E2A-HEB function and pre-Ta chain
expression. Nat. Immunol. 1, 138–144.
467E.-S. David-Fung et al. / Developmental Biology 325 (2009) 444–467Hernández-Hoyos, G., Anderson, M.K., Wang, C., Rothenberg, E.V., Alberola-Ila, J., 2003.
GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentia-
tion. Immunity 19, 83–94.
Ho, I.C., Pai, S.Y., 2007. GATA-3 — not just for Th2 cells anymore. Cell Mol. Immunol. 4,
15–29.
Hoffmann, R., Bruno, L., Seidl, T., Rolink, A., Melchers, F., 2003. Rules for gene usage
inferred from a comparison of large-scale gene expression proﬁles of T and B
lymphocyte development. J. Immunol. 170, 1339–1353.
Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y., Yokota, Y., 2001. Commitment to
natural killer cells requires the helix–loop–helix inhibitor Id2. Proc. Natl. Acad. Sci.
U. S. A 98, 5164–5169.
Inoue, J., Kanefuji, T., Okazuka, K., Watanabe, H., Mishima, Y., Kominami, R., 2006.
Expression of TCRab partly rescues developmental arrest and apoptosis of ab T cells
in Bcl11b−/− mice. J. Immunol. 176, 5871–5879.
Kawazu, M., Yamamoto, G., Yoshimi, M., Yamamoto, K., Asai, T., Ichikawa, M., Seo, S.,
Nakagawa, M., Chiba, S., Kurokawa, M., Ogawa, S., 2007. Expression proﬁling of
immature thymocytes revealed a novel homeobox gene that regulates double-
negative thymocyte development. J. Immunol. 179, 5335–5345.
Kirstetter, P., Anderson, K., Porse, B.T., Jacobsen, S.E., Nerlov, C., 2006. Activation of the
canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and
multilineage differentiation block. Nat. Immunol 7, 1048–1056.
Kusam, S., Toney, L.M., Sato, H., Dent, A.L., 2003. Inhibition of Th2 differentiation and
GATA-3 expression by BCL-6. J. Immunol. 170, 2435–2441.
Laiosa, C.V., Stadtfeld, M., Xie, H., Andres-Aguayo, L., Graf, T., 2006. Reprogramming of
committed Tcell progenitors tomacrophages and dendritic cells by C/EBPa and PU.1
transcription factors. Immunity 25, 731–744.
Lefebvre, J.M., Haks, M.C., Carleton, M.O., Rhodes, M., Sinnathamby, G., Simon, M.C.,
Eisenlohr, L.C., Garrett-Sinha, L.A., Wiest, D.L., 2005. Enforced expression of Spi-B
reverses T lineage commitment and blocks b-selection. J. Immunol. 174, 6184–6194.
Liu, P., Keller, J.R., Ortiz, M., Tessarollo, L., Rachel, R.A., Nakamura, T., Jenkins, N.A.,
Copeland, N.G., 2003. Bcl11a is essential for normal lymphoid development. Nat.
Immunol. 4, 525–532.
Loughran, S.J., Kruse, E.A., Hacking, D.F., de Graaf, C.A., Hyland, C.D., Willson, T.A.,
Henley, K.J., Ellis, S., Voss, A.K., Metcalf, D., Hilton, D.J., Alexander, W.S., Kile, B.T.,
2008. The transcription factor Erg is essential for deﬁnitive hematopoiesis and the
function of adult hematopoietic stem cells. Nat. Immunol. 9, 810–819.
Maeda, T., Merghoub, T., Hobbs, R.M., Dong, L., Maeda, M., Zakrzewski, J., van den Brink,
M.R., Zelent, A., Shigematsu, H., Akashi, K., Teruya-Feldstein, J., Cattoretti, G.,
Pandolﬁ, P.P., 2007. Regulation of B versus T lymphoid lineage fate decision by the
proto-oncogene LRF. Science 316, 860–866.
Morgan, B., Sun, L., Avitahl, N., Andrikopoulos, K., Ikeda, T., Gonzales, E., Wu, P., Neben, S.,
Georgopoulos, K., 1997. Aiolos, a lymphoid restricted transcription factor that
interacts with Ikaros to regulate lymphocyte differentiation. EMBO J.16, 2004–2013.
Murre, C., 2005. Helix–loop–helix proteins and lymphocyte development. Nat.
Immunol. 6, 1079–1086.
Nutt, S.L., Kee, B.L., 2007. The transcriptional regulation of B cell lineage commitment.
Immunity 26, 715–725.
Olman, V., Xu, D., Xu, Y., 2003. Identiﬁcation of regulatory binding sites using minimum
spanning trees. Pac. Symp. Biocomput. 327–338.
Petrie, H.T., Zuniga-Pﬂucker, J.C., 2007. Zoned out: functional mapping of stromal
signaling microenvironments in the thymus. Annu. Rev. Immunol. 25, 649–679.
Reya, T., O'Riordan, M., Okamura, R., Devaney, E., Willert, K., Nusse, R., Grosschedl, R.,
2000. Wnt signaling regulates B lymphocyte proliferation through a LEF-1
dependent mechanism. Immunity 13, 15–24.
Ross, I.L., Yue, X., Ostrowski, M.C., Hume, D.A., 1998. Interaction between PU.1 and
another Ets family transcription factor promotes macrophage-speciﬁc Basal
transcription initiation. J. Biol. Chem. 273, 6662–6669.
Rothenberg, E.V., 2007. Negotiation of the T lineage fate decision by transcription-factor
interplay and microenvironmental signals. Immunity 26, 690–702.
Rothenberg, E.V., Taghon, T., 2005. Molecular genetics of T cell development. Annu. Rev.
Immunol. 23, 601–649.
Rothenberg, E.V., Moore, J.E., Yui, M.A., 2008. Launching the T-cell-lineage develop-
mental programme. Nat. Rev. Immunol. 8, 9–21.
Sambandam, A., Maillard, I., Zediak, V.P., Xu, L., Gerstein, R.M., Aster, J.C., Pear, W.S.,
Bhandoola, A., 2005. Notch signaling controls the generation and differentiation of
early T lineage progenitors. Nat. Immunol. 6, 663–670.
Scheller, M., Huelsken, J., Rosenbauer, F., Taketo, M.M., Birchmeier, W., Tenen, D.G.,
Leutz, A., 2006. Hematopoietic stem cell and multilineage defects generated by
constitutive b-catenin activation. Nat. Immunol. 7, 1037–1047.
Schmitt, T.M., Zuniga-Pﬂucker, J.C., 2006. T-cell development, doing it in a dish.
Immunol. Rev. 209, 95–102.
Schmitt, T.M., Ciofani, M., Petrie, H.T., Zúñiga-Pﬂücker, J.C., 2004a. Maintenance of T cell
speciﬁcation and differentiation requires recurrent Notch receptor-ligand interac-
tions. J. Exp. Med. 200, 469–479.
Schmitt, T.M., De Pooter, R.F., Gronski, M.A., Cho, S.K., Ohashi, P.S., Zúñiga-Pﬂücker, J.C.,
2004b. Induction of T cell development and establishment of T cell competence
from embryonic stem cells differentiated in vitro. Nat. Immunol. 5, 410–417.
Shortman, K., Wu, L., 1996. Early T lymphocyte progenitors. Annu. Rev. Immunol. 14,
29–47.
Sieweke, M.H., Graf, T., 1998. A transcription factor party during blood cell differentia-
tion. Curr. Opin. Genet. Devel. 8, 545–551.
Singh, H., Pongubala, J.M., Medina, K.L., 2007. Gene regulatory networks that orchestrate
the development of B lymphocyte precursors. Adv. Exp. Med. Biol. 596, 57–62.
Spender, L.C., Whiteman, H.J., Karstegl, C.E., Farrell, P.J., 2005. Transcriptional cross-
regulation of RUNX1 by RUNX3 in human B cells. Oncogene 24, 1873–1881.Staal, F.J.T., Weerkamp, F., Langerak, A.W., Hendriks, R.W., Clevers, H.C., 2001.
Transcriptional control of T lymphocyte differentiation. Stem Cells 19, 165–179.
Staal, F.J.T., Weerkamp, F., Baert, M.R., van den Burg, C.M., van Noort, M., de Haas, E.F.,
van Dongen, J.J., 2004.Wnt target genes identiﬁed by DNAmicroarrays in immature
CD34+ thymocytes regulate proliferation and cell adhesion. J. Immunol. 172,
1099–1108.
Tabrizifard, S., Olaru, A., Plotkin, J., Fallahi-Sichani, M., Livak, F., Petrie, H.T., 2004.
Analysis of transcription factor expression during discrete stages of postnatal
thymocyte differentiation. J. Immunol. 173, 1094–1102.
Taghon, T.N., David, E.-S., Zúñiga-Pﬂücker, J.C., Rothenberg, E.V., 2005. Delayed,
asynchronous, and reversible T-lineage speciﬁcation induced by Notch/Delta
signaling. Genes Dev. 19, 965–978.
Taghon, T., Yui, M.A., Pant, R., Diamond, R.A., Rothenberg, E.V., 2006. Developmental and
molecular characterization of emerging b- and gd-selected pre-T cells in the adult
mouse thymus. Immunity 24, 53–64.
Taghon, T., Yui, M.A., Rothenberg, E.V., 2007. Mast cell lineage diversion of T lineage
precursors by the essential T-cell transcription factor GATA-3. Nat. Immunol. 8,
845–855.
Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E.S.,
Golub, T.R., 1999. Interpreting patterns of gene expression with self-organizing
maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad.
Sci. U. S. A 96, 2907–2912.
Tan, J.B., Visan, I., Yuan, J.S., Guidos, C.J., 2005. Requirement for Notch1 signals at
sequential early stages of intrathymic Tcell development. Nat. Immunol. 6, 671–679.
Tanigaki, K., Honjo, T., 2007. Regulation of lymphocyte development by Notch signaling.
Nat. Immunol. 8, 451–456.
Telfer, J.C., Rothenberg, E.V., 2001. Expression and function of a stem-cell promoter for
the murine CBFa2 gene: distinct roles and regulation in natural killer and T cell
development. Devel. Biol. 229, 363–382.
Thompson, E.C., Cobb, B.S., Sabbattini, P., Meixlsperger, S., Parelho, V., Liberg, D., Taylor,
B., Dillon, N., Georgopoulos, K., Jumaa, H., Smale, S.T., Fisher, A.G., Merkenschlager,
M., 2007. Ikaros DNA-binding proteins as integral components of B cell develop-
mental-stage-speciﬁc regulatory circuits. Immunity 26, 335–344.
Ting, C.-N., Olson, M.C., Barton, K.P., Leiden, J.M., 1996. Transcription factor GATA-3 is
required for development of the T-cell lineage. Nature 384, 474–478.
Tydell, C.C., David-Fung, E.-S., Moore, J.E., Rowen, L., Taghon, T., Rothenberg, E.V., 2007.
Molecular dissection of prethymic progenitor entry into the T lymphocyte
developmental pathway. J. Immunol. 179, 421–438.
Ullman, K.S., Northrop, J.P., Verweij, C.L., Crabtree, G.R.,1990. Transmission of signals from
the T lymphocyte antigen receptor to the genes responsible for cell proliferation and
immune function: the missing link. Ann. Rev. Immunol. 8, 421–452.
Vassen, L., Fiolka, K., Mahlmann, S., Moroy, T., 2005. Direct transcriptional repression of
the genes encoding the zinc-ﬁnger proteins Gﬁ1b and Gﬁ1 by Gﬁ1b. Nucleic Acids
Res. 33, 987–998.
Verbeek, S., Izon, D., Hofhuis, F., Robanus-Maandag, E., te Riele, H., Van de Wetering,
M., Oosterwegel, M., Wilson, A., MacDonald, H.R., Clevers, H., 1995. An HMG-
box-containing T-cell factor required for thymocyte differentiation. Nature 374,
70–74.
Wang, H., Diamond, R.A., Yang-Snyder, J.A., Rothenberg, E.V., 1998. Precocious
expression of T-cell functional response genes in vivo in primitive thymocytes
before T-lineage commitment. Int. Immunol. 10, 1623–1635.
Wang, D., John, S.A., Clements, J.L., Percy, D.H., Barton, K.P., Garrett-Sinha, L.A., 2005. Ets-
1 deﬁciency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and
autoimmune disease. Int. Immunol. 17, 1179–1191.
Wang, D., Claus, C.L., Vaccarelli, G., Braunstein, M., Schmitt, T.M., Zuniga-Pﬂucker, J.C.,
Rothenberg, E.V., Anderson, M.K., 2006. The basic helix–loop–helix transcription
factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell
precursors. J. Immunol. 177, 109–119.
Wilkinson, B., Chen, J.Y., Han, P., Rufner, K.M., Goularte, O.D., Kaye, J., 2002. TOX: an HMG
box protein implicated in the regulation of thymocyte selection. Nat. Immunol. 3,
272–280.
Xu, Y., Olman, V., Xu, D., 2002. Clustering gene expression data using a graph-theoretic
approach: an application of minimum spanning trees. Bioinformatics 18, 536–545.
Xue, H.-H., Bollenbacher, J., Rovella, V., Tripuraneni, R., Du, Y.-B., Liu, C.-Y., Williams, A.,
McCoy, J.P., Leonard, W.J., 2004. GA binding protein regulates interleukin 7 receptor
a-chain gene expression in T cells. Nat. Immunol. 5, 1036–1044.
Yamashita, M., Shinnakasu, R., Asou, H., Kimura, M., Hasegawa, A., Hashimoto, K.,
Hatano, N., Ogata, M., Nakayama, T., 2005. Ras-ERK MAPK cascade regulates GATA3
stability and Th2 differentiation through ubiquitin–proteasome pathway. J. Biol.
Chem. 280, 29409–29419.
Yao, Z., Cui, Y., Watford, W.T., Bream, J.H., Yamaoka, K., Hissong, B.D., Li, D., Durum, S.K.,
Jiang, Q., Bhandoola, A., Hennighausen, L., O'Shea, J.J., 2006. Stat5a/b are essential
for normal lymphoid development and differentiation. Proc. Natl. Acad. Sci. U. S. A.
103, 1000–1005.
Yin, Z., Chen, C., Szabo, S.J., Glimcher, L.H., Ray, A., Craft, J., 2002. T-Bet expression and
failure of GATA-3 cross-regulation lead to default production of IFN-g by gd Tcells. J.
Immunol. 168, 1566–1571.
Yui, M.A., Rothenberg, E.V., 2004. Deranged early T cell development in immunodeﬁ-
cient strains of nonobese diabetic mice. J. Immunol. 173, 5381–5391.
Yun, T.J., Bevan, M.J., 2003. Notch-regulated ankyrin-repeat protein inhibits Notch1
signaling: multiple Notch1 signaling pathways involved in T cell development. J.
Immunol. 170, 5834–5841.
Zaldumbide, A., Carlotti, F., Pognonec, P., Boulukos, K.E., 2002. The role of the Ets2
transcription factor in the proliferation, maturation, and survival of mouse
thymocytes. J. Immunol. 169, 4873–4881.
